平成4年7月1日 助手 岡山大学医学部細菌学講座
平成10年7月1日 同講師
平成11年7月16日 講師 岡山大学大学院医歯学総合研究科 (Dマル合教員)
平成17年4月1日 助教授 岡山大学医学部保健学科
平成20年4月1日 准教授 岡山大学大学院保健学研究科
平成28年4月1日 同教授
感染症学会評議員
ヘリコバクター学会代議員(耐性菌パネル委員)
Faculty Profiles
Updated on 2025/04/08
医学博士 ( 1999.6 岡山大学 )
Life Science / Bacteriology
Okayama University 医学部
- 1997.6
Notes: 医学博士
Okayama University Graduate School of Health Sciences Professor
2015.4
Okayama University Graduate School of Health Sciences Associate Professor
2005.4 - 2015.3
Okayama University Graduate School of Medicine , Dentistry and Pharmaceutical Sciences Lecturer
1998.7 - 2005.3
Okayama University Medical School Research Assistant
1992.8 - 1998.6
Sapporo Medical University 微生物学講座
1987.4 - 1992.6
Endoscopic and Histological Gastritis in University Students with Helicobacter pylori Infection.
Shotaro Okanoue, Hiroyuki Sakae, Kenji Yokota, Takehiro Tanaka, Yuka Obayashi, Makoto Abe, Yoshiyasu Kono, Hiromitsu Kanzaki, Masaya Iwamuro, Seiji Kawano, Yoshiro Kawahara, Hiroyuki Yanai, Hiroyuki Okada
Internal medicine (Tokyo, Japan) 63 ( 21 ) 2875 - 2884 2024.11
胃炎-胃癌患者の胃粘膜より分離された硝酸塩還元菌の性状
桑木 星里香, 山本 由弥子, 内山 淳平, 松下 治, 後藤 和義, 渡辺 朱理, 横田 憲治
日本細菌学雑誌 79 ( 2 ) 152 - 152 2024.6
基礎研究1 ピロリ菌感染モデルにおける細胞性免疫の低下と硝酸塩還元菌の影響
横田 憲治, 内山 淳平, 倉岡 紗樹子, 岡上 昇太郎, 河野 吉泰, 岡田 裕之
日本ヘリコバクター学会学術集会プログラム・抄録集 30回 70 - 70 2024.6
胃癌患者の胃内より分離した硝酸塩還元菌のピロリ菌共感染マウスへの影響
小松原 万里奈, 山本 由弥子, 内山 淳平, 松下 治, 後藤 和義, 渡辺 朱理, 横田 憲治
日本細菌学雑誌 79 ( 2 ) 140 - 140 2024.6
消化管細菌叢と胃の疾患 胃癌患者の胃内より分離される硝酸塩還元菌ついて
横田 憲治, 倉岡 紗樹子, 岡上 昇太郎, 河野 吉泰, 岡田 裕之
日本ヘリコバクター学会学術集会プログラム・抄録集 29回 95 - 95 2023.6
Helicobacter pylori感染胃炎における硝酸塩還元菌の胃内生息状況に関する検討
倉岡 紗樹子, 横田 憲治, 榮 浩行, 小嶋 日菜子, 岡上 昇太郎, 河野 吉泰, 岡田 裕之
日本ヘリコバクター学会誌 24 ( 2 ) 110 - 116 2023.1
Effects of Helicobacter pylori and Nitrate-Reducing Bacteria Coculture on Cells. International journal
Hinako Ojima, Sakiko Kuraoka, Shyoutarou Okanoue, Hiroyuki Okada, Kazuyoshi Gotoh, Osamu Matsushita, Akari Watanabe, Kenji Yokota
Microorganisms 10 ( 12 ) 2022.12
Helicobacter pylori感染胃炎における硝酸塩還元菌の胃内生息状況に関する検討
倉岡 紗樹子, 横田 憲治, 榮 浩行, 小嶋 日菜子, 岡上 昇太郎, 河野 吉泰, 岡田 裕之
日本ヘリコバクター学会学術集会プログラム・抄録集 28回 106 - 106 2022.6
若年者におけるヘリコバクターピロリ除菌治療による腸内細菌叢の変化についての検討
岡上 昇太郎, 後藤 和義, 倉岡 紗樹子, 稲生 祥子, 里見 拓也, 濱田 健太, 河野 吉泰, 神崎 洋光, 岩室 雅也, 川野 誠司, 河原 祥朗, 横田 憲治, 岡田 裕之
日本ヘリコバクター学会学術集会プログラム・抄録集 28回 103 - 103 2022.6
ヘリコバクター感染の基礎研究の現況 Helicobacter pyloriと共培養される胃内硝酸塩還元菌の細胞に対する作用
小嶋 日菜子, 倉岡 沙樹子, 岡上 昇太郎, 河野 吉泰, 岡田 裕之, 横田 憲治
日本ヘリコバクター学会学術集会プログラム・抄録集 28回 85 - 85 2022.6
Establishment of a reference panel of Helicobacter pylori strains for antimicrobial susceptibility testing. International journal
Kenji Yokota, Takako Osaki, Shunji Hayashi, Shin-Ichi Yokota, Hiroaki Takeuchi, Emiko Rimbara, Hinako Ojima, Toyotaka Sato, Hideo Yonezawa, Keigo Shibayama, Kengo Tokunaga, Shigeru Kamiya, Kazunari Murakami, Mototsugu Kato, Toshiro Sugiyama
Helicobacter 27 ( 3 ) e12874 2022.3
Use of ATP Bioluminescence Assay to Evaluate Oral Streptococci.
Akari Watanabe, Naofumi Tamaki, Kenji Yokota, Susumu Kokeguchi, Hiro-O Ito, Miwa Matsuyama
Biocontrol science 27 ( 4 ) 229 - 233 2022
Helicobacter pylori感染胃炎における硝酸塩還元菌の胃内生息状況に関する検討
倉岡 紗樹子, 横田 憲治, 榮 浩行, 岡上 昇太郎, 河野 吉泰, 岡田 裕之
日本ヘリコバクター学会学術集会プログラム・抄録集 27回 196 - 196 2021.9
大学新入生ピロリ検診の検討
岡上 昇太郎, 岡田 裕之, 田中 健大, 横田 憲治, 倉岡 紗樹子
日本ヘリコバクター学会学術集会プログラム・抄録集 27回 201 - 201 2021.9
Elizabethkingia anophelis, an emerging pathogen, inhibits RAW 264.7 macrophage function. International journal
I Putu Bayu Mayura, Kazuyoshi Gotoh, Hayato Nishimura, Erina Nakai, Takehiko Mima, Yumiko Yamamoto, Kenji Yokota, Osamu Matsushita
Microbiology and immunology 65 ( 8 ) 317 - 324 2021.8
Serodiagnosis and bacterial genome of helicobacter pylori infection
Aina Ichihara, Hinako Ojima, Kazuyoshi Gotoh, Osamu Matsushita, Susumu Take, Hiroyuki Okada, Akari Watanabe, Kenji Yokota
Toxins 13 ( 7 ) 2021.7
カルバペネマーゼ産生腸内細菌科細菌に対するビアペネムの殺菌効果
三好 諒, I Putu Bayu Mayura, 後藤 和義, 美間 健彦, 山本 由弥子, 横田 憲治, 松下 治, 萩谷 英大
日本細菌学雑誌 76 ( 1 ) 119 - 119 2021.2
敗血症性肺塞栓症患者から分離されたTsukamurella inchonensisの同定(Identification of Tsukamurella inchonensis isolated from septic pulmonary emboli(SPE) patient)
I Putu Bayu Mayura, Gotoh Kazuyoshi, 美間 健彦, 山本 由弥子, 横田 憲治, 松下 治, 萩谷 英大
日本細菌学雑誌 76 ( 1 ) 89 - 89 2021.2
Environmental survey of Methicillin-Resistant Staphylococci in a Hospital in Japan.
Akari Watanabe, Tokiko Watanabe, Susumu Kokeguchi, Yumiko Yamamoto, Osamu Matsushita, Kenji Yokota
Biocontrol science 26 ( 3 ) 137 - 145 2021
Antibacterial effects of disulfiram in helicobacter pylori
Tomomi Kobatake, Keiki Ogino, Hiroyuki Sakae, Kazuyoshi Gotoh, Akari Watanabe, Osamu Matsushita, Hiroyuki Okada, Kenji Yokota
Infection and Drug Resistance 14 1757 - 1764 2021
尿沈渣標本中に出現する顆粒状物質と尿路細菌叢との関連について
佐藤 妃映, 横田 憲治, 渡辺 朱理, 苔口 進, 衛藤 友美, 高阪 翔士
日本防菌防黴学会誌 48 ( 12 ) 623 - 628 2020.12
Correction to: Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication. Reviewed
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Chiaki Kusumoto, Takayuki Imada, Fumihiro Hamada, Tomowo Yoshida, Kenji Yokota, Toshiharu Mitsuhashi, Hiroyuki Okada
Journal of gastroenterology 55 ( 3 ) 289 - 290 2020.3
Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication. Reviewed
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Chiaki Kusumoto, Takayuki Imada, Fumihiro Hamada, Tomowo Yoshida, Kenji Yokota, Toshiharu Mitsuhashi, Hiroyuki Okada
Journal of gastroenterology 55 ( 3 ) 281 - 288 2020.3
Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome). International journal
Chihiro Kageyama, Takuro Igawa, Yuka Gion, Noriko Iwaki, Tetsuya Tabata, Takehiro Tanaka, Eisei Kondo, Hajime Sakai, Koichi Tsuneyama, Kazuhiro Nomoto, Hiroko Noguchi, Tadashi Yoshino, Kenji Yokota, Yasuharu Sato
Pathology international 69 ( 10 ) 572 - 579 2019.10
地域在住高齢者におけるメチシリン耐性ブドウ球菌の保菌状況調査
渡辺 朱理, 横田 憲治, 林 俊治, 苔口 進
日本環境感染学会総会プログラム・抄録集 34回 [P - 005] 2019.2
Increase in antibiotic resistant Helicobacter pylori in a University Hospital in Japan. International journal
Chihiro Kageyama, Mayu Sato, Hiroyuki Sakae, Yuka Obayashi, Yoshiro Kawahara, Takehiko Mima, Osamu Matsushita, Kenji Yokota, Motowo Mizuno, Hiroyuki Okada
Infection and drug resistance 12 597 - 602 2019
Association of host immunity with Helicobacter pylori infection in recurrent gastric cancer. International journal
Mayu Sato, Kou Miura, Chihiro Kageyama, Hiroyuki Sakae, Yuka Obayashi, Yoshiro Kawahara, Osamu Matsushita, Kenji Yokota, Hiroyuki Okada
Infectious agents and cancer 14 4 - 4 2019
A survey of Lasioderma serricorne (Fabricius) in Japanese Dental Clinics.
Akari Watanabe, Satoru Takaku, Kenji Yokota, Shunji Hayashi, Naofumi Tamaki, Susumu Kokeguchi
Biocontrol science 24 ( 2 ) 117 - 121 2019
吸い飲み内残余飲料の微生物汚染状況に関する実験的予備調査 Reviewed
渡辺朱理, 長岡仁美, 中江弘美, 吉岡昌美, 横田憲治, 松山美和, 苔口進
医学と生物学 159 ( 4 ) i4_Oj01 - 6 2019
Use of ATP bioluminescence to survey the spread of aerosol and splatter during dental treatments Reviewed
A. Watanabe, N. Tamaki, K. Yokota, M. Matsuyama, S. Kokeguchi
Journal of Hospital Infection 99 ( 3 ) 303 - 305 2018.7
Vibrio alginolyticus VepA Induces Lysosomal Membrane Permeability and Cathepsin-Independent Cell Death.
Agus Eka Darwinata, Kazuyoshi Gotoh, Takehiko Mima, Yumiko Yamamoto, Kenji Yokota, Osamu Matsushita
Acta medica Okayama 72 ( 3 ) 231 - 239 2018.6
井川 卓朗, 影山 千紘, 横田 憲治, 吉野 正, 佐藤 康晴
日本リンパ網内系学会会誌 58 122 - 122 2018.5
DEC205 mediates local and systemic immune responses to Helicobacter pylori infection in humans. International journal
Masahide Kita, Kenji Yokota, Chihiro Kageyama, Susumu Take, Kazuyoshi Goto, Yoshiro Kawahara, Osamu Matsushita, Hiroyuki Okada
Oncotarget 9 ( 22 ) 15828 - 15835 2018.3
Low incidence of esophageal adenocarcinoma after eradication of Helicobacter pylori in Japan. Reviewed International journal
Take S, Mizuno M, Ishiki K, Hamada F, Yoshida T, Yokota K, Okada H
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 16 ( 12 ) 1995 - 1996 2018.3
細菌性コラゲナーゼのPKDドメインの構造機能解析と骨新生誘導剤の開発(Structure analysis of bacterial collagenases to develop therapeutics to induce osteogenesis) Reviewed
松下 治, 内田 健太郎, 美間 健彦, 後藤 和義, 山本 由弥子, 横田 憲治, Bauer Ryan, 高相 晶士, Sakon Joshua
日本細菌学雑誌 73 ( 1 ) 114 - 114 2018.2
Elevated serum interferon gamma-induced protein 10 kDa is associated with TAFRO syndrome Reviewed
Noriko Iwaki, Yuka Gion, Eisei Kondo, Mitsuhiro Kawano, Taro Masunari, Hiroshi Moro, Koji Nikkuni, Kazue Takai, Masao Hagihara, Yuko Hashimoto, Kenji Yokota, Masataka Okamoto, Shinji Nakao, Tadashi Yoshino, Yasuharu Sato
SCIENTIFIC REPORTS 7 42316 2017.2
Monitoring of bacterial contamination of dental unit water lines using adenosine triphosphate bioluminescence. Reviewed International journal
Watanabe A, Tamaki N, Yokota K, Matsuyama M, Kokeguchi S
The Journal of hospital infection 94 ( 4 ) 393 - 396 2016.12
Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease Reviewed
Noriko Iwaki, David C. Fajgenbaum, Christopher S. Nabel, Yuka Gion, Eisei Kondo, Mitsuhiro Kawano, Taro Masunari, Isao Yoshida, Hiroshi Moro, Koji Nikkuni, Kazue Takai, Kosei Matsue, Mitsutoshi Kurosawa, Masao Hagihara, Akio Saito, Masataka Okamoto, Kenji Yokota, Shinichiro Hiraiwa, Naoya Nakamura, Shinji Nakao, Tadashi Yoshino, Yasuharu Sato
AMERICAN JOURNAL OF HEMATOLOGY 91 ( 2 ) 220 - 226 2016.2
Geranylgeranylacetone selectively binds to the HSP70 of Helicobacter pylori and alters its coccoid morphology Reviewed
Ewa Grave, Shin-ichi Yokota, Soh Yamamoto, Arisa Tamura, Takako Ohtaki-Mizoguchi, Kenji Yokota, Keiji Oguma, Kazuhiko Fujiwara, Nobuaki Ogawa, Tomoya Okamoto, Michiro Otaka, Hideaki Itoh
SCIENTIFIC REPORTS 5 13738 2015.9
渡辺 朱理, 横田 憲治, 松山 美和, 苔口 進
日本歯科衛生学会雑誌 10 ( 1 ) 120 - 120 2015.8
Signature-tagged mutagenesis of Vibrio vulnificus. Reviewed
Mai Yamamoto, Takashige Kashimoto, Ping Tong, Jianbo Xiao, Michiko Sugiyama, Miyuki Inoue, Rie Matsunaga, Kohei Hosohara, Kazue Nakata, Kenji Yokota, Keiji Oguma, Koichiro Yamamoto
The Journal of veterinary medical science 77 ( 7 ) 823 - 8 2015.7
Seventeen-year effects of eradicating Helicobacter pylori on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study Reviewed
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Fumihiro Hamada, Tomowo Yoshida, Kenji Yokota, Hiroyuki Okada, Kazuhide Yamamoto
JOURNAL OF GASTROENTEROLOGY 50 ( 6 ) 638 - 644 2015.6
Kita M, Take S, Okada H, Matsushita O, Yokota K
Rinsho byori. The Japanese journal of clinical pathology 63 ( 2 ) 180 - 186 2015.2
細菌必須遺伝子を標的とする阻害リード化合物の口腔細菌に対する効果
苔口 進, 狩山 玲子, 横田 憲治, 渡辺 朱理
日本環境感染学会誌 30 ( Suppl. ) 438 - 438 2015.1
環境汚染菌の消毒剤含浸ワイプによる拭き取り効果の検討
横田 憲治, 渡邉 都貴子, 林 俊治, 渡辺 朱理, 苔口 進, 平井 義一
日本環境感染学会誌 30 ( Suppl. ) 206 - 206 2015.1
Antibacterial activity of a novel synthetic progesterone species carrying a linoleic acid molecule against Helicobacter pylori and the hormonal effect of its steroid on a murine macrophage-like cell line Reviewed
Avarzed Amgalanbaatar, Hirofumi Shimomura, Kouichi Hosoda, Shunji Hayashi, Kenji Yokota, Yoshikazu Hirai
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 140 17 - 25 2014.3
病院内の環境細菌調査
横田 憲治, 渡邉 都貴子, 苔口 進, 林 俊治, 平井 義一
日本環境感染学会誌 29 ( Suppl. ) 287 - 287 2014.1
[New Helicobacters other than H. pylori]. Reviewed
Yokota K, Kita M, Okada H, Matsushita O, Oguma K
Nihon rinsho. Japanese journal of clinical medicine 71 ( 8 ) 1374 - 1379 2013.8
The Genetic Diversity of Helicobacter pylori Virulence Genes Is Not Associated with Gastric Atrophy Progression Reviewed
Masahide Kita, Kenji Yokota, Hiroyuki Okada, Susumu Take, Ryuta Takenaka, Yoshiro Kawahara, Keiji Oguma, Osamu Matsushita, Kazuhide Yamamoto
ACTA MEDICA OKAYAMA 67 ( 2 ) 93 - 98 2013.4
Detoxification of 7-Dehydrocholesterol Fatal to Helicobacter pylori Is a Novel Role of Cholesterol Glucosylation Reviewed
Hirofumi Shimomura, Kouichi Hosoda, David J. Mcgee, Shunji Hayashi, Kenji Yokota, Yoshikazu Hirai
JOURNAL OF BACTERIOLOGY 195 ( 2 ) 359 - 367 2013.1
Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan Reviewed
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Takayuki Imada, Tetsuji Okuno, Tomowo Yoshida, Kenji Yokota, Keiji Oguma, Masahide Kita, Hiroyuki Okada, Kazuhide Yamamoto
JOURNAL OF GASTROENTEROLOGY 47 ( 6 ) 641 - 646 2012.6
Clostridium botulinum Type E Toxins Bind to Caco-2 Cells by a Different Mechanism from That of Type A Toxins Reviewed
Kai Zhang, Yumiko Yamamoto, Tomonori Suzuki, Kenji Yokota, Shaobo Ma, Ni Nengah Dwi Fatmawati, Keiji Oguma
ACTA MEDICA OKAYAMA 66 ( 3 ) 253 - 261 2012.6
Phosphatidylethanolamine of Helicobacter pylori Functions as a Steroid-Binding Lipid in the Assimilation of Free Cholesterol and 3 beta-Hydroxl Steroids into the Bacterial Cell Membrane Reviewed
Hirofumi Shimomura, Kouichi Hosoda, Shunji Hayashi, Kenji Yokota, Yoshikazu Hirai
JOURNAL OF BACTERIOLOGY 194 ( 10 ) 2658 - 2667 2012.5
Role of heat shock protein derived from Streptococcus sanguinis in Behcet’s disease Reviewed
Kaneko F, Togashi A, Nomura E, Isogai E, Yokota K, Oguma K
J Med Micorobiol Diagnosis 2012
Steroid hormones as bactericidal agents to Helicobacter pylori Reviewed
Kouichi Hosoda, Hirofumi Shimomura, Shunji Hayashi, Kenji Yokota, Yoshikazu Hirai
FEMS MICROBIOLOGY LETTERS 318 ( 1 ) 68 - 75 2011.5
The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori Reviewed
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Tomowo Yoshida, Nobuya Ohara, Kenji Yokota, Keiji Oguma, Hiroyuki Okada, Kazuhide Yamamoto
JOURNAL OF GASTROENTEROLOGY 46 ( 3 ) 318 - 324 2011.3
Behcet's Disease (Adamantiades-Behcet's Disease) Reviewed
Fumio Kaneko, Ari Togashi, Sanae Saito, Hideo Sakuma, Noritaka Oyama, Koichiro Nakamura, Kenji Yokota, Keiji Oguma
CLINICAL & DEVELOPMENTAL IMMUNOLOGY 2011 681956 2011
Passive Oral Immunization by Egg Yolk Immunoglobulin (IgY) to Vibrio cholerae Effectively Prevents Cholera Reviewed
Kazuyuki Hirai, Hideyuki Arimitsu, Koji Umeda, Kenji Yokota, Lianhua Shen, Kiyoshi Ayada, Yoshikatsu Kodama, Takao Tsuji, Yoshikazu Hirai, Keiji Oguma
ACTA MEDICA OKAYAMA 64 ( 3 ) 163 - 170 2010.6
コレラ菌およびコレラ毒素Bサブユニットに対するニワトリ抗体(IgY)の有用性
平井 一行, 衛藤 友美, 大野 佑子, 田村 臣哉, 山本 由弥子, 難波 ひかる, 阪口 義彦, 横田 憲治, 小熊 惠二
日本薬学会年会要旨集 130年会 ( 3 ) 84 - 84 2010.3
Steroids mediate resistance to the bactericidal effect of phosphatidylcholines against Helicobacter pylori Reviewed
Hirofumi Shimomura, Kouichi Hosoda, Shunji Hayashi, Kenji Yokota, Keiji Oguma, Yoshikazu Hirai
FEMS MICROBIOLOGY LETTERS 301 ( 1 ) 84 - 94 2009.12
Detection of Helicobacter hepaticus in Human Bile Samples of Patients with Biliary Disease Reviewed
Toshihide Hamada, Kenji Yokota, Kiyoshi Ayada, Kazuyuki Hirai, Tomoari Kamada, Ken Haruma, Kazuaki Chayama, Keiji Oguma
HELICOBACTER 14 ( 6 ) 545 - 551 2009.12
Regulation of cellular immunity prevents Helicobacter pylori-induced atherosclerosis Reviewed
K. Ayada, K. Yokota, K. Hirai, K. Fujimoto, K. Kobayashi, H. Ogawa, K. Hatanaka, S. Hirohata, T. Yoshino, Y. Shoenfeld, E. Matsuura, K. Oguma
LUPUS 18 ( 13 ) 1154 - 1168 2009.11
Anabolic utilization of steroid hormones in Helicobacter pylori Reviewed
Kouichi Hosoda, Hirofumi Shimomura, Shunji Hayashi, Kenji Yokota, Keiji Oguma, Yoshikazu Hirai
FEMS MICROBIOLOGY LETTERS 297 ( 2 ) 173 - 179 2009.8
Chronic Infections and Atherosclerosis Reviewed
Kiyoshi Ayada, Kenji Yokota, Kazuko Kobayashi, Yehuda Shoenfeld, Eiji Matsuura, Keiji Oguma
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY 37 ( 1 ) 44 - 48 2009.8
Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis: Prospective endoscopic evaluation Reviewed
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Yasuhiro Nagahara, Tomowo Yoshida, Kenji Yokota, Keij Oguma, Hiroyuki Okada, Kazuhide Yamamoto
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 24 ( 1 ) 107 - 113 2009.1
Helicobacter pylori heat shock protein 60 antibodies are associated with gastric cancer Reviewed
Aki Tanaka, Tomoari Kamada, Kenji Yokota, Akiko Shiotani, Jiro Hata, Keiji Oguma, Ken Haruma
PATHOLOGY RESEARCH AND PRACTICE 205 ( 10 ) 690 - 694 2009
Immune Reactions Against Elongation Factor 2 Kinase: Specific Pathogenesis of Gastric Ulcer from Helicobacter pylori Infection Reviewed
Kiyoshi Ayada, Kenji Yokota, Yoshiro Kawahara, Yumiko Yamamoto, Kazuyuki Hirai, Tomoki Inaba, Masahide Kita, Hiroyuki Okada, Kazuhide Yamamoto, Keiji Oguma
CLINICAL & DEVELOPMENTAL IMMUNOLOGY 2009
The role of streptococcal hypersensitivity in the pathogenesis of Behcet's Disease Reviewed
Fumio Kaneko, Noritaka Oyama, Hirokatsu Yanagihori, Emiko Isogai, Kenji Yokota, Keiji Oguma
EUROPEAN JOURNAL OF DERMATOLOGY 18 ( 5 ) 489 - 498 2008.9
Antibodies against heat shock protein 60 derived from Helicobacter pylori: Diagnostic implications in cardiovascular disease
Tomoyuki Okada, Kiyoshi Ayada, Shinichi Usui, Kenji Yokota, Jinhua Cui, Yoshiro Kawahara, Tomoki Inaba, Satoshi Hirohata, Motowo Mizuno, Daisuke Yamamoto, Shozo Kusachi, Eiji Matsuura, Keiji Oguma
Journal of Autoimmunity 29 ( 2-3 ) 106 - 115 2007.9
Conversion of flavodoxin from holoenzyme to apoprotein during growth phase changes in Helicobacter pylori Reviewed
Hirofumi Shimomura, Shunji Hayashi, Kenji Yokota, Keiji Oguma, Yoshikazu Hirai
JOURNAL OF BACTERIOLOGY 189 ( 13 ) 4960 - 4963 2007.7
Helicobacter pylori heat-shock protein 60 induces interleukin-8 via a Toll-like receptor (TLR)2 and mitogen-activated protein (MAP) kinase pathway in human monocytes Reviewed
Ying Zhao, Kenji Yokota, Kiyoshi Ayada, Yumiko Yamamoto, Tomayuki Okada, Lianhua Shen, Keiji Oguma
JOURNAL OF MEDICAL MICROBIOLOGY 56 ( 2 ) 154 - 164 2007.2
Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases Reviewed
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Yasuhiro Nagahara, Tomowo Yoshida, Kenji Yokota, Keiji Oguma
JOURNAL OF GASTROENTEROLOGY 42 21 - 27 2007.1
A better cure rate with 800 mg than with 400 mg clarithromycin regimens in one-week triple therapy for Helicobacter pylori infection in cigarette-smoking peptic ulcer patients Reviewed
Hidehiko Ishioka, Motowo Mizuno, Susumu Take, Kuniharu Ishiki, Yasuhiro Nagahara, Tomowo Yoshida, Hiroyuki Okada, Kenji Yokota, Keiji Oguma
DIGESTION 75 ( 2-3 ) 63 - 68 2007
Chronic infections and atherosclerosis
Kiyoshi Ayada, Kenji Yokota, Kazuko Kobayashi, Yehuda Shoenfeld, Eiji Matsuura, Keiji Oguma
Annals of the New York Academy of Sciences 1108 594 - 602 2007
Jae-Chul Lee, Kenji Yokota, Hideyuki Arimitsu, Hyun-Jung Hwang, Yoshihiko Sakaguchi, Jinhua Cui, Kouichi Takeshi, Toshihiro Watanabe, Tohru Ohyama, Keiji Oguma
Microbiology 151 ( 11 ) 3739 - 3747 2005.11
HLA-DQA1*0103-DQB1*0601 haplotype and Helicobacter pylori-positive gastric mucosa-associated lymphoid tissue lymphoma Reviewed
Yoshiro Kawahara, Motowo Mizuno, Tadashi Yoshino, Kenji Yokota, Keiji Oguma, Hiroyuki Okada, Shigeatsu Fujiki, Yasushi Shiratori
Clinical Gastroenterology and Hepatology 3 ( 9 ) 865 - 868 2005.9
The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease Reviewed
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Yasuhiro Nagahara, Tomowo Yoshida, Kenji Yokota, Keiji Oguma, Hiroyuki Okada, Yasushi Shiratori
American Journal of Gastroenterology 100 ( 5 ) 1037 - 1042 2005.5
Neutrophil and lymphocyte responses to oral Streptococcus in Adamantiades-Behcet's disease Reviewed
T Kurauchi, K Yokota, T Matsuo, Y Fujinami, E Isogai, H Isogai, H Ohtsuki, K Oguma
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 43 ( 2 ) 125 - 131 2005.2
Alteration in the composition of cholesteryl glucosides and other lipids in Helicobacter pylori undergoing morphological change from spiral to coccoid form Reviewed
Hirofumi Shimomura, Shunji Hayashi, Kenji Yokota, Keiji Oguma, Yoshikazu Hirai
FEMS Microbiology Letters 237 ( 2 ) 407 - 413 2004.8
Helicobacter pylori Eradication Improves Pre-Existing Reflux Esophagitis in Patients With Duodenal Ulcer Disease Reviewed
Kuniharu Ishiki, Motowo Mizuno, Susumu Take, Yasuhiro Nagahara, Tomowo Yoshida, Kazuhide Yamamoto, Hiroyuki Okada, Kenji Yokota, Keiji Oguma, Yasushi Shiratori
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2 ( 6 ) 474 - 479 2004.6
H. pylori decreases gastric mucin synthesis via inhibition of galactosyltransferase
Shouichi Tanaka, Motowo Mizuno, Toshirou Maga, Fumiya Yoshinaga, Jun Tomoda, Junichirou Nasu, Hiroyuki Okada, Kenji Yokota, Keiji Oguma, Yasushi Shiratori, Takao Tsuji
Hepato-Gastroenterology 50 ( 53 ) 1739 - 1742 2003.9
Outcome of patients with inconsistent results from 13C-urea breath test and bacterial culture at the time of assessment of Helicobacter pylori eradication therapy in Japan
Yasuhiro Nagahara, Motowo Mizuno, Toshirou Maga, Kuniharu Ishiki, Tetsuji Okuno, Tomowo Yoshida, Kenji Yokota, Keiji Oguma, Hiroyuki Okada, Takao Tsuji
Hepato-Gastroenterology 50 ( 53 ) 1700 - 1703 2003.9
Antimicrobial activity of synthetic human CAP18 peptides to Streptococcus sanguis isolated from patients with Behcet's disease Reviewed
E Isogai, M Hirata, H Isogai, K Matuo, K Kimura, K Yokota, K Oguma, M Tojo, F Kaneko, S Kotake, S Ohno
ADAMANTIADES-BEHCET'S DISEASE 528 195 - 200 2003
Interleukin-1β Genetic Polymorphism Influences the Effect of Cytochrome P 2C19 Genotype on the Cure Rate of 1-Week Triple Therapy for Helicobacter pylori Infection
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Yasuhiro Nagahara, Tomowo Yoshida, Tomoki Inaba, Kazuhide Yamamoto, Hiroyuki Okada, Kenji Yokota, Keiji Oguma, Yasushi Shiratori
American Journal of Gastroenterology 98 ( 11 ) 2403 - 2408 2003
Concurrent gastric and colonic low-grade mucosa-associated lymphoid tissue lymphomata in a patient without Helicobacter pylori infection
Hiroyuki Okada, Motowo Mizuno, Tadashi Yoshino, Kenji Yokota, Hiroaki Okazaki, Nobuaki Okano, Junichirou Nasu, Tomohiko Mannami, Keiji Oguma, Tadaatsu Akagi, Takao Tsuji, Yasushi Shiratori
Digestive Endoscopy 15 ( 1 ) 55 - 59 2003
Characterisation of monoclonal antibodies against haemagglutinin associated with Clostridium botulinum type C neurotoxin Reviewed International journal
NAZIRA MAHMUT, KAORU INOUE, YUKAKO FUJINAGA, LYNN HUGHES, HIDEYUKI ARIMITSU, YOSHIHIKO SAKAGUCHI, AIJI OHTSUKA, TAKURO MURAKAMI, KENJI YOKOTA, KEIJI OGUMA
Journal of Medical Microbiology 51 ( 4 ) 286 - 294 2002.4
Bacteriology of H. pylori
Keiji Oguma, Kenji Yokota, Yoshikazu Hirai, Shunji Hayashi
Nippon rinsho. Japanese journal of clinical medicine 60 74 - 83 2002
Antibody to heat shock protein can be used for early serological monitoring of Helicobacter pylori eradication treatment Reviewed
N Yunoki, K Yokota, M Mizuno, Y Kawahara, M Adachi, H Okada, S Hayashi, Y Hirai, K Oguma, T Tsuji
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 7 ( 4 ) 574 - 577 2000.7
Characterization of hemagglutinin activity of clostridium botulinum type A, C and D HA positive progenitor toxins and type D HA1
Kaoru Inoue, Yukako Fujinaga, Kenji Yokota, Toshihiro Watanabe, Kouichi Takeshi, Tohru Ohyama, Katsuhiro Inoue, Keiji Oguma
Japanese Journal of Infectious Diseases 53 ( 1 ) 32 - 33 2000.2
Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells Reviewed
S Hayashi, T Sugiyama, K Yokota, H Isogai, E Isogai, H Shimomura, K Oguma, N Asaka, Y Hirai
MICROBIOLOGY AND IMMUNOLOGY 44 ( 7 ) 557 - 562 2000
Funamori Yuka, Fujinaga Yukako, Yokota Kenji, Inoue Kaoru, Hirai Yoshikazu, Oguma Keiji, Kira Shohei, Taketa Kazuhisa
Acta Medica Okayama 53 ( 4 ) 193 - 200 1999.8
Expression and characterization of the hemagglutinin-subcomponents of Clostridium botulinum type C progenitor toxin
Yukako Fujinaga, Kaoru Inoue, Kenji Yokota, Kouichi Takeshi, Tohru Ohyama, Toshihiro Watanabe, Katsuhiro Inoue, Keiji Oguma
Japanese Journal of Infectious Diseases 52 ( 1 ) 27 1999.2
Kaoru Inoue, Yukako Fujinaga, Koichi Honke, Kenji Yokota, Tetsuya Ikeda, Tohru Ohyama, Kouichi Takeshi, Toshihiro Watanabe, Katsuhiro Inoue, Keiji Oguma
Microbiology 145 ( 9 ) 2533 - 2542 1999
Antibody and cytokine responses in Helicobacter-pylori-infected various mouse strains Reviewed
A Dey, K Yokota, K Kosavashi, K Oguma, Y Hirai, T Akagi
ACTA MEDICA OKAYAMA 52 ( 1 ) 41 - 48 1998.2
Analysis of immunoglobulin A antibodies to Helicobacter pylori in serum and gastric juice in relation to mucosal inflammation Reviewed
Hayashi, S, Sugiyama, T, Yokota, K, Isogai, H, Isogai, E, Oguma, K, Asaka, M, Fujii, N, Hirai, Y
Clin. Diag. Labo. Immunol. 5 ( 5 ) 617 - 621 1998
Detection of Helicobacter pylori associated antigen and heat shock protein 60 on follicular dendritic cells in the germinal centres of low grade B cell lymphoma of gastric mucosa associated lymphoid tissue (MALT)
Keita Kobayashi, Kenji Yokota, Tadashi Yoshino, Yoshiro Kawahara, Ashoka Dey, Yoshikazu Hirai, Keiji Oguma, Tadaatsu Akagi
Journal of Clinical Pathology 51 ( 5 ) 396 - 398 1998
Modification of Helicobacter pylori adhesion to human gastric epithelial cells by antiadhesion agents
S. Hayashi, T. Sugiyama, M. Asaka, K. Yokota, K. Oguma, Y. Hirai
Digestive Diseases and Sciences 43 ( 9 ) 1998
IgA protease produced by Streptococcus sanguis and antibody production against IgA protease in patients with Behcet's disease Reviewed
K Yokota, K Oguma
MICROBIOLOGY AND IMMUNOLOGY 41 ( 12 ) 925 - 931 1997
Brief communication: A rapid and simple method to quantify Helicobacter pylori adhesion to human gastric MKN-28 cells
Shunji Hayashi, Toshiro Sugiyama, Akira Yachi, Kenji Yokota, Yoshikazu Hirai, Keiji Oguma, Nobuhiro Fujii
Journal of Gastroenterology and Hepatology (Australia) 12 ( 5 ) 373 - 375 1997
80 尋常性乾癬患者におけるCandida albicans血中抗体価の特徴と時間的推移について
田中 智, 山本 美保, 飯田 憲治, 松田 三千雄, 林 俊治, 横田 憲治, 小熊 恵二
アレルギー 45 ( 8 ) 900 - 900 1996
Lipid profile of Helicobacter spp.: Presence of cholesteryl glucoside as a characteristic feature
Mahmudul Haque, Yoshikazu Hirai, Kenji Yokota, Noriko Mori, Israt Jahan, Hideyuki Ito, Hisako Hotta, Ikuya Yano, Yasuhiro Kanemasa, Keiji Oguma
Journal of Bacteriology 178 ( 7 ) 2065 - 2070 1996
LIPID PROFILES OF HELICOBACTER-PYLORI AND HELICOBACTER-MUSTELAE GROWN IN SERUM-SUPPLEMENTED AND SERUM-FREE MEDIA Reviewed
M HAQUE, Y HIRAI, K YOKOTA, K OGUMA
ACTA MEDICA OKAYAMA 49 ( 4 ) 205 - 211 1995.8
240 尋常性乾癬におけるCandida albicans血中抗体価の検討
田中 智, 飯田 憲治, 松田 三千雄, 林 俊治, 続 佳代, 横田 憲治, 小熊 恵二
アレルギー 44 ( 3 ) 414 - 414 1995
231 アトピー性皮膚炎におけるCandida albicans血中抗体価の検討
飯田 憲治, 田中 智, 林 俊治, 続 佳代, 松田 三千雄, 横田 憲治, 小熊 恵二
アレルギー 44 ( 3 ) 412 - 412 1995
Unique cholesteryl glucosides in Helicobacter pylori: Composition and structural analysis
Y. Hirai, M. Haque, T. Yoshida, K. Yokota, T. Yasuda, K. Oguma
Journal of Bacteriology 177 ( 18 ) 5327 - 5333 1995
HELICOBACTER-PYLORI INDUCES INFLAMMATION IN MOUSE URINARY-BLADDER AND PELVIS Reviewed
H ISOGAI, E ISOGAI, K KIMURA, N FUJII, K YOKOTA, K OGUMA
MICROBIOLOGY AND IMMUNOLOGY 38 ( 5 ) 331 - 336 1994
Heat Shock Protein Produced by Helicobacter pylori
Yokota Kenji, Hirai Yoshikazu, Haque Mahmudul, Hayashi Shyunji, Isogai Hiroshi, Sugiyama Toshiro, Nagamachi Eiko, Tsukada Yutaka, Fujii Nobuhiro, Oguma Keiji
Japanese Journal of Microbiology 38 ( 5 ) 403 - 405 1994
356 アトピー性皮膚炎におけるCandida albicans血中抗体価の検討
飯田 憲治, 田中 智, 横田 憲治, 小熊 恵二, 松田 三千雄
アレルギー 42 ( 9 ) 1398 - 1398 1993
Lipid composition of Helicobacter pylori
Y. Hirai, M. Haque, K. Yokota, K. Oguma
Nippon rinsho. Japanese journal of clinical medicine 51 ( 12 ) 3094 - 3101 1993
Experimental animal models in Mongolian gerbils and mice
H. Isogai, E. Isogai, K. Yokota, K. Oguma
Nippon rinsho. Japanese journal of clinical medicine 51 ( 12 ) 3138 - 3143 1993
P 140 Characterization and functional properties of Streptococcus sanguis isolated from patient with Behçet's disease
E. Isogai, K. Yokota, N. Fujii, S. Hayashi, K. Kimura, H. Isogai, N. Ishii, Y. Yamakawa, H. Nakajima, S. Ohno, S. Kotake, K. Oguma
La Revue de medecine interne 14 ( 1 ) 123 1993
Antibody Response to Oral Streptococci in Behçet's Disease
YOKOTA Kenji, HAYASHI Syunji, FUJII Nobuhiro, YOSHIKAWA Kouji, KOTAKE Satoshi, ISOGAI Emiko, OHNO Shigeaki, ARAKI Yoshio, OGUMA Keiji
Japanese Journal of Microbiology 36 ( 8 ) 815 - 822 1992
Colonization of Helicobacter pylori in the Gastric Mucosa of Mongolian Gerbils
Kenji Yokota, Keiji Oguma, Shunji Hayashi, Yoshikazu Takayama, Kouzou Imai, Tsuyoshi Yabana, Akira Yachi, Hiroshi Isogai, Emiko Isogai, Youichi Kurebayashi
Microbiology and Immunology 35 ( 6 ) 475 - 480 1991
胃壁中のCampylobacter pyloriの同定法の検討と血中抗菌抗体の測定 Reviewed
横田憲治, 小熊恵二, 吉田博清, 高山義一, 杉山敏郎, 矢花 剛, 谷内 昭, 榑林陽一, 磯貝 浩, 磯貝恵美子
感染症学会誌 64 597 - 603 1990
Close association of Streptococcus sanguis uncommon serotypes with Behcet's disease Reviewed
Isogai, E, Ohno, S, Takeshi, K, Yoshikawa, K, Tsurumizu, T, Isogai, H, Yokota, K, Kotake, S, Sasamoto, Y, Hashimoto, T, Shimizu, H, Fujii, N, Yamaguchi, M, Oguma, K
Bifidobact. Microflora 9 27 - 41 1990
Chemiluminescence of neutrophils from patients with Behçet's disease and its correlation with an increased proportion of uncommon serotypes of Streptococcus sanguis in the oral flora
E. Isogai, S. Ohno, S. Kotake, H. Isogai, T. Tsurumizu, N. Fujii, K. Yokota, B. Syuto, M. Yamaguchi, H. Matsuda, K. Oguma
Archives of Oral Biology 35 ( 1 ) 43 - 48 1990
Effects of nitrate-reducing bacteria from the gastric cancer patients in H. pylori co-infected mice
小松原万里奈, 山本由弥子, 内山淳平, 松下治, 後藤和義, 渡辺朱理, 横田憲治
日本細菌学雑誌(Web) 79 ( 2 ) 2024
The panel of antibiotic-resistant strains of Helicobacter pylori
林俊治, 大崎敬子, 竹内啓晃, 横田憲治, 横田伸一, 林原絵美子
日本細菌学雑誌(Web) 27回 ( 1 ) 180 - 180 2021.9
尿沈渣標本中に出現する顆粒状物質と尿路感染症細菌との関連について
佐藤 妃映, 横田 憲治, 渡辺 朱理, 苔口 進, 衛藤 友美, 高阪 翔士
日本環境感染学会総会プログラム・抄録集 33回 297 - 297 2018.2
環境汚染菌の消毒剤および除菌洗浄剤含浸ワイプによる拭き取り除去効果
横田 憲治, 渡邉 都貴子, 林 俊治, 渡辺 朱理, 苔口 進, 平井 義一, 松下 治
日本防菌防黴学会誌 46 ( 1 ) 3 - 8 2018.1
環境汚染菌の消毒剤および除菌洗浄剤含浸ワイプによる拭き取り除去効果
横田 憲治, 渡邉 都貴子, 林 俊治, 渡辺 朱理, 苔口 進, 平井 義一, 松下 治
日本防菌防黴学会誌 46 ( 1 ) 3 - 8 2018.1
歯科予防処置における飛散汚染状況調査 ATP測定法と細菌培養法からの検討
渡辺 朱理, 苔口 進, 横田 憲治, 松山 美和
日本歯科衛生学会雑誌 12 ( 1 ) 145 - 145 2017.8
Beyondボノプラザン標準療法 当院における3次除菌療法(PPI/P-CAB+AMPC+STFX)とペニシリンアレルギーに対する治療成績の検討
榮 浩行, 横田 憲治, 大林 由佳, 河野 吉泰, 三浦 公, 岡田 裕之
日本ヘリコバクター学会学術集会プログラム・抄録集 23回 90 - 90 2017.6
H.pylori感染胃炎の内視鏡診断の進歩 H.pylori除菌後再感染は、内視鏡所見で診断できるか?
大林 由佳, 武 進, 榮 浩行, 河野 吉泰, 三浦 公, 楠本 智章, 横田 憲治, 水野 元夫, 岡田 裕之
日本ヘリコバクター学会学術集会プログラム・抄録集 23回 109 - 109 2017.6
エアロゾルサンプルからの非結核性抗酸菌の分離検出
平井 一行, 横田 憲治, 平井 義一
日本環境感染学会総会プログラム・抄録集 32回 257 - 257 2017.2
細菌性コラゲナーゼのマトリックス・アンカーの構造解析と骨新生誘導のための複合剤開発(Structural analysis of a matrix anchor in bacterial collagenase to develop an osteogenic therapeutic)
松下 治, 内田 健太郎, 関口 裕之, 美間 健彦, 後藤 和義, 山本 由弥子, 横田 憲治, 高相 晶士, Bauer Ryan, Sakon Joshua
日本細菌学雑誌 72 ( 1 ) 109 - 109 2017.2
Vibrio alginolyticusのコラゲナーゼ発現はHapRにより調節される(Expression of colA is regulated by HapR in Vibrio alginolyticus)
美間 健彦, 西川 裕太郎, 中田 悠介, 波多野 直哉, 後藤 和義, 山本 由弥子, 横田 憲治, 松下 治
日本細菌学雑誌 72 ( 1 ) 106 - 106 2017.2
腸肝在位Helicobacter感染症研究の最前線 肝胆道系疾患とヘパティカス菌感染
横田 憲治
日本細菌学雑誌 72 ( 1 ) 32 - 32 2017.2
Vibrio alginolyticusのコラゲナーゼ発現はHapRにより調節される(Expression of colA is regulated by HapR in Vibrio alginolyticus)
美間 健彦, 西川 裕太郎, 中田 悠介, 波多野 直哉, 後藤 和義, 山本 由弥子, 横田 憲治, 松下 治
日本細菌学雑誌 72 ( 1 ) 106 - 106 2017.2
渡辺 朱理, 横田 憲治, 苔口 進, 松山 美和
日本歯科衛生学会雑誌 11 ( 1 ) 152 - 152 2016.8
合成コラーゲン様基剤とコラーゲン結合型線維芽細胞増殖因子を用いた複合剤による骨形成促進法の開発
濱本 奈々, 内田 健太郎, 関口 裕之, 美間 健彦, 後藤 和義, 山本 由弥子, 横田 憲治, 高相 晶士, 松下 治
日本細菌学雑誌 71 ( 1 ) 126 - 126 2016.2
Vibrio alginolyticus I.029のコラゲナーゼ発現はHapRにより調節される
西川 裕太郎, 美間 健彦, 中田 悠介, 後藤 和義, 山本 由弥子, 横田 憲治, 松下 治
日本細菌学雑誌 71 ( 1 ) 127 - 127 2016.2
口腔内におけるメトロニダゾール耐性歯周病細菌の調査
苔口 進, 渡辺 朱理, 横田 憲治
日本環境感染学会誌 31 ( Suppl. ) 478 - 478 2016.2
歯ブラシへの付着・残存口腔内細菌調査
長瀬 優里, 苔口 進, 横田 憲治, 松山 美和, 渡辺 朱理
四国公衆衛生学会雑誌 61 ( 1 ) 87 - 92 2016.2
Examination of the Antimicrobial and Cleaning Effects of Commercially Available Soaps
YOSHIDA Yoko, WATANABE Tokiko, HAYASHI Shunji, HIRAI Yoshikazu, YOKOTA Kenji
40 ( 11 ) 685 - 691 2012.11
THERAPEUTIC POSSIBILITY FOR PATIENTS WITH BEHCET'S DISEASE BY THE PEPTIDES OF HEAT SHOCK PROTEIN-65/60 DERIVED FROM ORAL STREPTOCOCCI
Fumio Kaneko, Ari Togashi, Noritaka Oyama, Koichiro Nakamura, Emiko Isogai, Kenji Yokota, Keiji Oguma
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 28 ( 4 ) S119 - S119 2010.7
ROLE OF ORAL STREPTOCOCCI IN THE PATHOGENESIS OF BEHCET'S DISEASE
Fumio Kaneko, Noritaka Oyama, Hirokatsu Yanagihori, Emiko Isogai, Kenji Yokota, Keiji Oguma
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 26 ( 4 ) S16 - S16 2008.7
Eradication of Helicobacter pylori before the significant expansion of mucosal atrophy is most beneficial to prevent gastric cancer
Motowo Mizuno, Susumu Take, Yasuhiro Nagahara, Kuniharu Ishiki, Tomowo Yoshida, Kenji Yokota, Keiji Oguma
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 22 A63 - A63 2007.10
H. pylori-抗原刺激によるマンノースレセプターファミリーDEC205のマクロファージでの発現
藤本 聖人, 横田 憲治, 趙 瑩, 綾田 潔, 小熊 惠二
日本細菌学雑誌 62 ( 1 ) 169 - 169 2007.2
ヘリコバクター・ピロリのフラボドキシン代謝におけるクラスC酸性ホスファターゼの関与
下村 裕史, 林 俊治, 横田 憲治, 小熊 恵二, 平井 義一
日本細菌学雑誌 62 ( 1 ) 87 - 87 2007.2
Vibrio vulnificus 弱毒化株のマウス感染実験におけるワクチン効果
瀬川 理恵, 井上 美幸, 横田 憲治, 小熊 惠二, 山本 耕一郎
日本細菌学雑誌 62 ( 1 ) 172 - 172 2007.2
署名Tagトランスポゾン挿入変異法による Vibrio vulnificus 弱毒化変異株の分離
細原 浩平, 瀬川 理恵, 光原 沙織, 菅 悠喜, 横田 憲治, 小熊 惠二, 山本 耕一郎
日本細菌学雑誌 62 ( 1 ) 126 - 126 2007.2
申 蓮花, 横田 憲治, 綾田 潔, 阪口 義彦, 平井 一行, 長町 栄子, 小熊 惠二
日本細菌学雑誌 62 ( 1 ) 74 - 74 2007.2
胆汁検体よりの Helicobacter 属の存在確認と培養の試み
横田 憲治, 綾田 潔, 阪口 義彦, 藤本 聖人, 長町 榮子, 小熊 惠二
日本細菌学雑誌 62 ( 1 ) 179 - 179 2007.2
Behcet病発症における細菌抗原の意義 (第1土曜特集 Behcet病--病因の解明と難治性病態の克服に向けて) -- (病因・病態)
横田 憲治, 小熊 惠二
医学のあゆみ 215 ( 1 ) 19 - 22 2005.10
H. cinaedi, H. fenneliae, H. pullorum の性状と病原性
平井 義一, 下村 裕史, 林 俊治, 横田 憲治, 小熊 恵二
臨床と微生物 = Clinical microbiology 32 ( 2 ) 175 - 180 2005.3
Helicobacter pylori heat-shock protein 60 induces production of the pro-inflammatory cytokine IL8 in monocytic cells
SN Lin, K Ayada, Y Zhao, K Yokota, R Takenaka, H Okada, R Kan, S Hayashi, M Mizuno, Y Hirai, Y Fujinami, K Oguma
JOURNAL OF MEDICAL MICROBIOLOGY 54 ( 3 ) 225 - 233 2005.3
Mechanisms of inflammation induced by H. pylori-HSP60
Kenji Yokota, Kiyoshi Ayada, Son-NanLin, Keiji Oguma, Ryuta Takenaka
Nippon rinsho. Japanese journal of clinical medicine 63 75 - 79 2005
Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the toll-like receptor-triggered pathway in cultured human gastric epithelial cells
R Takenaka, K Yokota, K Ayada, M Mizuno, Y Zhao, Y Fujinami, SN Lin, T Toyokawa, H Okada, Y Shiratori, K Oguma
MICROBIOLOGY-SGM 150 3913 - 3922 2004.12
Serum antibodies to Helicobacter pylori and its heat shock protein 60 correlate with the response of gastric mucosa-associated lymphoid tissue lymphoma to eradication of H. pylori
R Takenaka, H Okada, M Mizuno, C Makidono, SI Hori, A Fujiwara, T Yoshino, K Yokota, K Oguma, Y Shiratori
GASTROENTEROLOGY 126 ( 4 ) A181 - A181 2004.4
Characterization of elongated Helicobacter pylori isolated from a patient with gastric-mucosa-associated lymphoid-tissue lymphoma
T Toyokawa, K Yokota, M Mizuno, Y Fujinami, R Takenaka, H Okada, S Hayashi, Y Hirai, K Oguma, Y Shiratori
JOURNAL OF MEDICAL MICROBIOLOGY 53 ( 3 ) 207 - 212 2004.3
ボツリヌスB型神経毒素に結合している無毒成分の免疫増強作用について
李 在哲, 横田 憲治, 崔 錦花, 有満 秀幸, 阪口 義彦, 藤永 由佳子, 金 英姫, 松村 拓大, 株本 祐子, 小熊 恵二
日本細菌学雑誌 59 ( 1 ) 282 - 282 2004.2
Immune response in Helicobacter pylori-induced low-grade gastric-mucosa-associated lymphoid tissue (MALT) lymphoma
R Yamasaki, K Yokota, H Okada, S Hayashi, M Mizuno, T Yoshino, Y Hirai, D Saitou, T Akagi, K Oguma
JOURNAL OF MEDICAL MICROBIOLOGY 53 ( 1 ) 21 - 29 2004.1
胃MALTリンパ腫に対するHelicobacter pylori(HP)除菌療法後の経過とsecond line治療としての放射線療法へのタイミング
岡田裕之, 水野元夫, 白鳥康史, 吉野 正, 横田憲治
消化器科 38,1,53-58 2004
神経変性疾患髄液中の抗Helicobacter pylori heat shock protein 60抗体の検出
齊藤 正樹, 千葉 進, 青木 雅俊, 松本 博之, 杉山 敏郎, 藤永 由佳子, 横田 憲治, 藤浪 良仁, 小熊 恵二
臨床神経学 43 ( 12 ) 1069 - 1069 2003.12
Heat shock protein 60 of Helicobacter pylori induces inflammatory responses through the toll-like receptor-triggered pathway in cultured human gastric epithelial cells
R Takenaka, K Yokota, M Mizuno, Y Fujinami, T Toyokawa, S Hiraoka, S Hori, C Makidono, S Take, H Okada, K Oguma, Y Shiratori
GASTROENTEROLOGY 124 ( 4 ) A590 - A590 2003.4
Mucosal immunisation with Clostridium botulinum type C16Stoxoid and its non-toxic component
N Mahmut, K Inoue, Y Fujinaga, H Arimitsu, Y Sakaguchi, L Hughes, R Hirst, T Murphy, T Tsuji, T Watanabe, T Ohyama, T Karasawa, S Nakamura, K Yokota, K Oguma
JOURNAL OF MEDICAL MICROBIOLOGY 51 ( 10 ) 813 - 820 2002.10
Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype
T Inaba, M Mizuno, K Kawai, K Yokota, K Oguma, M Miyoshi, S Take, H Okada, T Tsuji
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 17 ( 7 ) 748 - 753 2002.7
Reinfection rate following effective therapy against Helicobacter pylori infection in Japan
M Adachi, M Mizuno, K Yokota, M Miyoshi, Y Nagahara, T Maga, K Ishiki, T Inaba, H Okada, K Oguma, T Tsuji
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 17 ( 1 ) 27 - 31 2002.1
臨床 H.pyloriのゲノムと病原性 (特集 微生物ゲノム情報と医学--基礎と臨床)
林 俊治, 平井 義一, 横田 憲治
現代医療 34 ( 5 ) 1091 - 1096 2002
Expression of heat shock protein 60 in normal and neoplastic human lymphoid tissues.
JIN Hua Shu, YOSHINO Tadashi, JIN Zaishun, OKA Takashi, KOBAYASHI Keita, YAMASAKI Rie, LIU Yi Xuan, YOKOTA Kenji, OGUMA Keiji, AKAGI Tadaatsu
J.Clin.Exp. Hematopathol 1, 25-32 ( 1 ) 25 - 32 2002
Immunoglobulin G1 antibody response to Helicobacter pylori heat shock protein 60 is closely associated with low-grade gastric mucosa-associated lymphoid tissue lymphoma
E Ishii, K Yokota, T Sugiyama, Y Fujinaga, K Ayada, Hokari, I, S Hayashi, Y Hirai, M Asaka, K Oguma
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 8 ( 6 ) 1056 - 1059 2001.11
牛乳由来 globotriaosylceramide によるベロ毒素の細胞障害能の抑制
ターナ, 渡来 仁, 児玉 洋, 櫛 泰典, 井上 薫, 横田 憲治, 小熊 恵二
脂質生化学研究 43 203 - 206 2001.5
Inhibition of vero cell cytotoxic activity in Escherichia coli O157 : H7 lysates by globotriaosylceramide, Gb3, from bovine milk
S Watarai, Tana, K Inoue, Y Kushi, E Isogai, K Yokota, K Naka, K Oguma, H Kodama
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY 65 ( 2 ) 414 - 419 2001.2
Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera
S Watarai, K Yokota, Tana, T Kishimoto, T Kanadani, K Taketa, K Oguma
JOURNAL OF CLINICAL MICROBIOLOGY 39 ( 2 ) 798 - 800 2001.2
H. pylori感染と胃粘膜免疫応答.
横田憲治, 綾田 潔, 石井栄子, 山崎理恵, 小林計太, 吉野 正, 林 俊治, 平井義一, 赤木忠厚, 小熊恵二
日本臨床 59,342-348 2001
A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism
Masatsugu Miyoshi, Motowo Mizuno, Kuniharu Ishiki, Yasuhiro Nagahara, Toshirou Maga, Tomomi Torigoe, Junichirou Nasu, Hiroyuki Okada, Kenji Yokota, Keiji Oguma, Takao Tsuji
Journal of Gastroenterology and Hepatology (Australia) 16 ( 7 ) 723 - 728 2001
Gastric mucosal immunity induced by H. pylori infection
K. Yokota, K. Ayada, E. Ishii, K. Oguma, R. Yamasaki, K. Kobayashi, T. Yoshino, T. Akagi, S. Hayashi, Y. Hirai
Nippon rinsho. Japanese journal of clinical medicine 59 ( 2 ) 342 - 348 2001
CAP18(抗菌および抗エンドトキシン蛋白)の生体防御因子としての役割
平田陸正, 切替照雄, 横田憲治, 田村弘志, 田中重則, 小熊恵二, 佐藤成大
日本細菌学雑誌 55 ( 2 ) 347 2000.4
The Bacteriocidal Effect of the Electrolysed Functioning Water against Helicobacter pylori
NAKAO Miyuki, YOKOTA Kenji, OGUMA Keiji, TAKAI Kenichi
74 ( 2 ) 120 - 127 2000.2
H. pyloriの胃リンパ腫への関与
吉野 正, 赤木忠厚, 横田憲治, 小熊恵二, 河原祥朗
癌の臨床 46:839-845 2000
Treatment of Helicobacter pylori infection
Hayashi, S, Hirai, Y, Isogai, H, Isogai, E, Yokota, K, Oguma, K
Res. Adv. Antimicrob. Chemother. 1 7 - 12 2000
Association of Helicobacter pylori with gastroduodenal diseases
Y Hirai, S Hayashi, H Shimomura, K Oguma, K Yokota
JAPANESE JOURNAL OF INFECTIOUS DISEASES 52 ( 5 ) 183 - 197 1999.10
Antibodies to human gastric epithelial cells and heat shock protein 60 in Helicobacter pylori positive mucosa associated lymphoid tissue lymphoma
Y Kawahara, K Yokota, M Mizuno, N Yunoki, T Uesu, H Okada, K Kobayashi, Y Hirai, K Oguma, T Tsuji
GUT 45 ( 1 ) 20 - 23 1999.7
小熊 惠二, 藤永 由佳子, 井上 薫, 横田 憲治, 武士 甲一
最新医学 54 ( 増刊 ) 652 - 664 1999.3
ボツリヌスprogenitor toxinのHAサブコンポーネントの小腸微絨毛及び赤血球への結合活性について
藤永 由佳子, 井上 薫, 横田 憲治, 長町 榮子, 小熊 惠二
日本細菌学雑誌 54 ( 1 ) 117 - 117 1999.2
Helicobacter pyloriのHSP60の発現と生物活性の検討
横田 憲治, 石井 栄子, 綾田 潔, 平井 義一, 林 俊治, 藤永 由佳子, 小熊 惠二
日本細菌学雑誌 54 ( 1 ) 212 - 212 1999.2
岡山県における腸管出血性大腸菌O157:H7の分子疫学的検討
船守 有香, 横田 憲治, 藤永 由佳子, 井上 薫, 小熊 惠二
日本細菌学雑誌 54 ( 1 ) 203 - 203 1999.2
Gastric ulcers in SCID mice induced by Helicobacter pylori infection after transplanting lymphocytes from patients with gastric lymphoma
YOKOTA K
Gastroenterology 117 893 - 899 1999
Structure and function of Clostridium botulinum progenitor toxin
K Oguma, K Inoue, Y Fujinaga, K Yokota, T Watanabe, T Ohyama, K Takeshi, K Inoue
JOURNAL OF TOXICOLOGY-TOXIN REVIEWS 18 ( 1 ) 17 - 34 1999
Classification of Clostridium butyricum based on sodium dodecyl sulfate polyacrylamide gel electrophoresis and pulsed-field gel electrophoresis
K Yokota, Y Fujinaga, K Inoue, S Shimazaki, G Seo, K Takeshi, E Nagamachi, K Oguma
ANAEROBE 4 ( 4 ) 177 - 181 1998.8
Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells
S Hayashi, T Sugiyama, KI Amano, H Isogai, E Isogai, M Aihara, M Kikuchi, M Asaka, K Yokota, K Oguma, N Fujii, Y Hirai
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 42 ( 8 ) 1895 - 1899 1998.8
ボツリヌス毒素
小熊 惠二, 井上 薫, 藤永 由佳子, 横田 憲治, 武士 甲一, 大山 徹, 池田 徹也, 渡部 俊弘, 井上 勝弘
Modern Media 44 ( 7 ) 9-18,213-222 - 222 1998.7
Helicobacter pyloriのワクチン療法 (特集 Helicobacter pyloriの基礎と臨床)
小熊 恵二, 横田 憲治, 平井 義一
診断と治療 86 ( 1 ) 89 - 94 1998.1
The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin
Y Fujinaga, K Inoue, S Watanabe, K Yokota, Y Hirai, E Nagamachi, K Oguma
MICROBIOLOGY-UK 143 3841 - 3847 1997.12
Effect of ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells
HAYASHI Shunji, SUGIYAMA Toshiro, YACHI Akira, YOKOTA Kenji, HIRAI Yoshikazu, OGUMA Keiji, FUJII Nobuhiro
32 ( 5 ) 593 - 597 1997.10
井上 薫, 藤永 由佳子, 横田 憲治
蛋白質核酸酵素 42 ( 13 ) 2049 - 2060 1997.10
Helicobacter pylori. Prospects on development of Helicobacter pylori vaccine.
OGUMA KEIJI, HIRAI YOSHIKAZU, YOKOTA KENJI
臨床検査 41 ( 2 ) 185 - 188 1997.2
Structure and function of Clostridium botulinum progenitor toxins
K. Inoue, Y. Fujinaga, K. Yokota, K. Oguma
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme 42 ( 13 ) 2049 - 2060 1997
Helicobacter pylori and gastroduodenal disease
K Yokota, Y Hirai, K Oguma
JAPANESE JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH 42 ( 3 ) 193 - 209 1996.6
Quantitative detection of secretory immunoglobulin a to Helicobacter pylori in gastric juice: Antibody capture enzyme-linked immunosorbent assay
S Hayashi, T Sugiyama, K Hisano, T Awakawa, Kurokawa, I, A Yachi, H Isogai, E Isogai, K Yokota, Y Hirai, K Oguma, N Fujii
JOURNAL OF CLINICAL LABORATORY ANALYSIS 10 ( 2 ) 74 - 77 1996
Characterization of Streptococcus sanguis Isolated from Patients with Behcet's Disease
YOKOTA Kenji, HAYASHI Shynji, ARAKI Yoshio, ISOGAI Emiko, KOTAKE Satoshi, YOSHIKAWA Kouji, FUJII Nobuhiro, HIRAI Yoshikazu, OGUMA Keiji
Microbiol Immunol 39 ( 9 ) 729 - 732 1995.9
スナネズミおよびマウスを用いる感染実験モデル. Helicobacter pylori と胃粘膜障害
磯貝 浩, 磯貝恵美子, 横田憲治, 小熊恵二
日本臨床 51 ( 12 ) 3183 - 3143 1993
Hayashi Shunji, Yokota Kenji, Takizawa Yoshihiko, Tomizawa Isao, Nejime Tetsuya, Oguma Keiji
Japanese Journal of Microbiology 37 ( 4 ) 271 - 279 1993
Demonstration of antigen-specific immune response against Streptococcus sanguis
Norihisa Ishii, Emiko Isogai, Yuko Yamakawa, Hiroshi Nakajima, Shigeaki Ohno, Hiroshi Isogai, Shunji Hayashi, Kenji Yokota, Keiji Oguma
Journal of Dermatological Science 5 ( 3 ) 182 - 189 1993
A NOVEL ENZYME-IMMUNOASSAY FOR SERODIAGNOSIS OF HELICOBACTER-PYLORI INFECTION
T SUGIYAMA, K IMAI, H YOSHIDA, Y TAKAYAMA, T YABANA, K YOKOTA, K OGUMA, A YACHI
GASTROENTEROLOGY 101 ( 1 ) 77 - 83 1991.7
PLATELET-AGGREGATION INDUCED BY UNCOMMON SEROTYPES OF STREPTOCOCCUS-SANGUIS ISOLATED FROM PATIENTS WITH BEHCETS-DISEASE
E ISOGAI, H ISOGAI, K YOKOTA, S HAYASHI, N FUJII, K OGUMA, K YOSHIKAWA, Y SASAMOTO, S KOTAKE, S OHNO
ARCHIVES OF ORAL BIOLOGY 36 ( 6 ) 425 - 429 1991
Adhesive properties of streptococcus sanguis isolated from patients with behçet's disease
E. Isogap, H. Isogai, N. Fujii, K. Yokota, M. Yamaguchi, K. Oguma, K. Yoshikawa, Y. Sasamoto, S. Ohnot
Microbial Ecology in Health and Disease 3 ( 6 ) 321 - 328 1990
新興病原体エリザベスキンギア菌によるマクロファージ成熟抑制現象の解明
Grant number:22K07069 2022.04 - 2026.03
日本学術振興会 科学研究費助成事業 基盤研究(C)
後藤 和義, 横田 憲治, 中山 真彰
Grant amount:\4160000 ( Direct expense: \3200000 、 Indirect expense:\960000 )
オゾン水の歯科医療環境感染予防対策実用化に向けた研究
Grant number:22K10290 2022.04 - 2025.03
日本学術振興会 科学研究費助成事業 基盤研究(C)
渡辺 朱理, 横田 憲治, 玉木 直文, 松山 美和
Grant amount:\4160000 ( Direct expense: \3200000 、 Indirect expense:\960000 )
プロトンポンプ阻害剤服用時に歯周病原細菌が腸内細菌叢へ及ぼす影響
Grant number:21K09893 2021.04 - 2024.03
日本学術振興会 科学研究費助成事業 基盤研究(C)
平井 公人, 横田 憲治, 高柴 正悟
Grant amount:\4160000 ( Direct expense: \3200000 、 Indirect expense:\960000 )
本研究の目的は胃酸分泌抑制剤であるプロトンポンプ阻害薬(PPI)の服用により胃酸の殺菌作用が低下した状態で,歯周病原細菌であるPorphyromonas. gingivalisもしくはその代謝産物が腸内細菌叢へ与える影響を調査することである。健康なマウスでは経口投与された細菌はほとんどが胃酸で殺菌されるが,PPI投与により胃酸の殺菌作用が低下した状態ではP.gingivalisは胃を生菌として通過し遠位腸管まで到達できるかどうかを検討した。
まずはPPIであるランソプラゾールのマウスへの経口投与が胃酸のpHをどの程度上昇させるかを検討するためにPPI投与後24時間後に安楽死させ切除した胃の内容物のpHを計測した。PPI投与群でも非投与群でもpHは2-3程度と差がなかった。これはマウスの餌の摂取制限ができないために胃内容物が多かったことが原因と考えられるため,今後はPPIの薬効の確認には血中ガストリン濃度の測定などで評価する必要がある。
歯周病感染モデルではマウスに1週間PPIの経口投与を行った後にP.gingivalisを2日間経口投与し,24時間後に盲腸の糞便を回収した。回収した糞便から約10mg採取し変法GAMブイヨン寒天培地上で嫌気培養し得られた菌体から採取したDNAと,盲腸糞便から直接採取したDNAを用いてP.gingivalisを特異的に認識するプライマーを用いてのDNA量をリアルタイムPCR法を用いて評価したとこと,PPIの有無に関わらず盲腸内で生菌としては確認されなかったが,盲腸内からはP.gingivalis遺伝子を確認することができた。また大腸組織の病理学的評価においてはPPI投与群で非投与群に比べてP.gingivalis経口投与によると思われる腸管粘膜の炎症性細胞浸潤や腸管上皮の傷害などの炎症所見が重症化する傾向にあった。
ピロリ菌感染に伴う硝酸塩還元菌の胃内動向と疾患との関連
Grant number:21K07366 2021.04 - 2024.03
日本学術振興会 科学研究費助成事業 基盤研究(C)
横田 憲治, 岡田 裕之, 渡辺 朱理
Grant amount:\4290000 ( Direct expense: \3300000 、 Indirect expense:\990000 )
胃癌(intestinal type)は日本人に多いがんであり、その原因はHelicobacter pylori(ピロリ菌)の高い感染率に由来している。ピロリ菌感染は、その他にも胃炎や胃粘膜委縮を起こし、消化性潰瘍、MALTリンパ腫の原因になる。胃癌以外の疾患は除菌により治癒するものがあるが、胃癌は除菌のみでは治癒できない。高齢者は感染率が高く、除菌している人も多いが、除菌後でも胃癌を発症する人はいる。この除菌後の胃癌発症は、長期のピロリ菌感染による胃粘膜萎縮が治らないためと考えられる。また萎縮胃粘膜においては、胃の酸度が低下し、胃内が中性化することによって、他の常在菌の繁殖が起こってくる。これら常在菌の中には発癌物質を産生する硝酸塩還元菌が存在し、胃癌発症の要因となる可能性がある。これら硝酸塩還元菌の胃内分布と炎症や発癌における役割を研究する。ピロリ菌による胃粘膜萎縮が発癌物質であるN-ニトロソ化合物を産生する硝酸塩還元菌の胃粘膜での増加と関係している可能性があり、ピロリ菌感染による発がん機構の新しい原因が証明できる可能性がある。ピロリ菌感染の影響による硝酸塩還元菌の胃への定着と増加が証明されれば新しい概念を提唱できる可能性がある。1)ピロリ菌培養の時に同時に培養される常在菌を分離培養し、硝酸塩還元能を調べる。2)硝酸塩還元菌のDNAを抽出し16SrDNAの配列から菌種を同定する。3)硝酸塩還元菌の炎症反応との関係を、単球系培養細胞を使い検討する。4)細胞性免疫を抑制した、マウスモデルに投与し、発癌するか調べる。
ピロリ菌除菌療法における腸内エコシステム破綻のメカニズムと制御
Grant number:19K08395 2019.04 - 2023.03
日本学術振興会 科学研究費助成事業 基盤研究(C)
岡田 裕之, 後藤 和義, 横田 憲治, 松下 治, 田中 健大, 岡上 昇太郎
Grant amount:\4160000 ( Direct expense: \3200000 、 Indirect expense:\960000 )
大学新入生において標準的なピロリ菌除菌レジメンの下で下痢・軟便を主とした副作用を起こす患者の腸内細菌叢に共通するファクターを見出すことを目的とする。さらにはメタゲノムデータと常在細菌叢の抗菌薬感受性を融合させることで、なぜ特定の菌叢を持つ(または持たない)ことでDysbiosisが起こるのか、そ のメカニズムを説明する。さらに内視鏡的胃炎、組織学的胃炎評価も行い、最終的に腸内細菌叢解析データと融合する。2019年度から岡山大学医学部・歯学部新入生(医学科・保健学科・歯学部)に対してピロリ菌検診を例年通り実施し、H.pylori-IgG抗体陽性例を本研究の対象とする。 2019年度は新入生314人中17人が抗体陽性であった。また,2020年度は新入生320人中12人が抗体陽性であった。抗体陽性者のうち内視鏡検査を受けた14人に内視鏡的胃炎、組織学的胃炎の評価および菌株培養を行った。組織学的陽性例は現感染と診断した。組織学的胃炎、菌株培養陰性例に対しては、さらに尿素呼気試験も行い、それら3検査とも陰性の場合は抗体検査が偽陽性と判断し、未感染と診断した。その結果、現感染11名、未感染3名であった。現感染者には除菌治療を行い、除菌前、除菌1週後、2ケ月後の糞便採取を行うとともに、 除菌前後2週間の排便回数も含めた消化管症状についてアンケートを実施した。未感染者に対して も1回糞便採取とアンケートを実施した。 得られた糞便の核酸を抽出し、16SrRMA遺伝子のシークエンスにより糞便細菌菌叢解析を行った。α多様性分析では腸内細菌叢の多様性は、治療により一時的に減少するが、除菌2か月後には治療前のレベルにおおむね回復した。また、除菌直後はクレブシエラ属細菌の有意な増加を認めたが、除菌2か月後には治療前のレベルに減少した。
Survay on carcinogenic risks by oral bacteria and their measures
Grant number:19K10087 2019.04 - 2022.03
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
Kokeguchi Susumu
Grant amount:\4290000 ( Direct expense: \3300000 、 Indirect expense:\990000 )
Helicobacter pylori is a well-known bacterial carcinogen in gastric cancer. The possible association between intestinal bacterial flora and colorectal cancer has been also most studied. The several oral bacteria species such as Fusobacterium nucleatum etc. have been frequently isolated from various cancer regions. However, the relationship between oral bacteria and cancer development remains inadequate. The aim of this study is to reveal direct or indirect carcinogenic potential in oral bacteria. The extracts of F. nucteatum was not mutagenic in the Ames test. Several Nitrate-reducing oral bacteria, including Actinomyces and Streptococcus were isolated from the Gastroscopy samples in the gastric precancerous state, which produce the main carcinogenic N-nitroso compounds. These bacteria showed the potential production of inflammatory mediators such as IL-8 and TNF-α with THP cells in the relation to mutagenesis. The genome analyses of oral bacteria to find oncoprotein CagA are ongoing.
Detection of nontuberculous mycobacteria (NTM) from shower aerosols and automatic endoscope washers
Grant number:18K10016 2018.04 - 2021.03
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
Hirai Kazuyuki
Grant amount:\4550000 ( Direct expense: \3500000 、 Indirect expense:\1050000 )
The purpose of this study was the investigation of nontuberuculous mycobacteria (NTM) in shower water, shower aerosols and automatic endoscope washer.
By replacing the shower head with a sterile-grade water filter, the number of NTM colony-forming units in the shower water and aerosols samples was below the detection levels.
We conducted the survey on the NTM contamination of six automatic endoscope washers before and after use before maintenance and before use after maintenance. NTM was detected only three times of 54 surveys on the day before maintenance.
Diagnosis of gastric cancer due to Helicobacter pylori infection and analysis of mechanism
Grant number:18K07447 2018.04 - 2021.03
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
Yokota Kenji
Grant amount:\4420000 ( Direct expense: \3400000 、 Indirect expense:\1020000 )
1) Th1 / 2 immunity and gastric cancer: An infected mouse model was created, and blood sampling was performed to monitor the antibody titer subclass. After confirming infection in all mice, cytokines were administered to each mouse to induce an immune response between Th1 and Th2. From the measurement results of the IgG1 / IgG2 subclass, and 20U administration is effective in inducing immunity for cytokine administration. In addition, it was found that cell-mediated immunity was suppressed and humoral immunity was predominant in the IL-10-administered group than in the IFN-γ-administered group.
2) Cistatin A: We investigated whether Cystatin A was affected by the antigens used for stimulation during culture and various cytokines. PMA or GM-CSF / IL-4 stimulation reduced the expression of Cystatin A. The expression of Cystatin A was considered to be related to the activation of immune functions such as cytokine stimulation.
Establishment of new infection control for home dental care environment as indicator of oral pathogenic bacteria
Grant number:17K12008 2017.04 - 2020.03
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
WATANABE Akari
Grant amount:\4550000 ( Direct expense: \3500000 、 Indirect expense:\1050000 )
The opportunities of home dental care for elderly in need of nursing care and immunocompromised patients have been increasing. The improvement and establishment of the infection control for home dental care under differing environment with dental clinic are present urgent issues. The purpose of this study was to investigate the pollution status of the environments during home dental care and the habitat of oral pathogenic bacteria in the elderly in need of nursing care at home. This study revealed the spread of the community-acquired methicillin-resistant staphylococci in their oral cavities. It is necessary to pay attention to their future trends. The ATP measurement values used for the survey of environmental cleanliness showed the positive correlation with the number of bacteria in oral cavity, which could be led to the oral hygiene state evaluation.
Construction of standard environmental infection prevention system in Home Dental Care
Grant number:26463163 2014.04 - 2017.03
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
WATANABE Akari
Grant amount:\4940000 ( Direct expense: \3800000 、 Indirect expense:\1140000 )
Home Dental Care, also called Domiciliary Oral Healthcare, is a special dental service that elderly requiring long-term care or immunocompromised patients receive in their home. So, the most urgent problem is maintenance and improvement of infection control for Home Dental Care environment. The aim of this study was to investigate the cleanness and microbial contamination in Home Dental Care environment which has not been reported. It was revealed the surrounding environment during Home Dental Care treatments were exposed by aerosol and droplets scattering from patients’ saliva including oral bacteria and adequate oral hygiene management would lead to environmental infection prevention. The ATP-bioluminescence method and the survey for the pathogenic pest were possibly easy and quick methods to evaluate visually the cleanness and contamination in Home Dental Care environment. They were also useful and effective for the environmental hygiene monitoring and management.
Study on the elucidation and prevention for cardiovascular disorder by HACEK group oral bacteria
Grant number:23390428 2011.04 - 2014.03
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)
KOKEGUCHI Susumu, MAEDA Hiroshi, MURAKAMI Jun, KARIYAMA Reiko, YOKOTA Kenji, NISHIMURA Fusanori
Grant amount:\19370000 ( Direct expense: \14900000 、 Indirect expense:\4470000 )
Several microbiologic and epidemiologic studies have suggested an association between oral bacteria and systemic health such as diabetes, respiratory diseases and cardiovascular diseases. The HACEK organisms (Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, and Kingella species) among oral bacteria are noted as the pathogens of infective endocarditis. The aim of this study is to determine the possible pathogenic factors of Aggregatibacter actinomycetemcomitans and oral methanogenic Archaea on infective endocarditis, and to analyze clinical and microbiological characteristics of the patients with infective endocarditis. Cell surface enolase and RNA chaperone protein, Hfq in A. actinomycetemcomitans and group II chaperonin of oral methanogenic Archaea were further characterized. The antimicrobial activity of inhibitor for methionine aminopeptidase and vitamin K analogues were also examined as a candidate of new therapeutic agents.
Role of macrophage in Helicobacter pylori infection
Grant number:20590445 2008 - 2010
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
YOKOTA Kenji, AYADA Kiyoshi, OGUMA Kenji
Grant amount:\4810000 ( Direct expense: \3700000 、 Indirect expense:\1110000 )
Expression of DEC205, which is antigen uptake receptor on macrophage, was increased in H.pylori infected patients with early gastric cancer. However mRNA of DEC205 was also increased in the patient without gastric cancer. Expression of Th1 cytokines was detected in lymphocyte stimulated with HSP60 from patients with gastric cancer. HSP60 stimulation and its response in T helper CD4 may be available for diagnosis or prediction of gastric cancer caused by H.pylori infection. On the other hand, HSP60 antibody may be associated with cardiovascular disease (CVD) induced by H.pylori infection.
Establishment of new procedure for botulism including bioterrorism, and application of botulinum toxin to the treatment
Grant number:19390126 2007 - 2008
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)
OGUMA Keiji, YOKOTA Kenji, AYADA Kiyoshi, SAKAGUCHI Yoshihiko, YAMAMOTO Yumiko, ARIMITSU Hideyuki
Grant amount:\19110000 ( Direct expense: \14700000 、 Indirect expense:\4410000 )
ボツリヌス菌や毒素、抗毒素抗体の検出方法と毒素の治療への応用を検討した。菌の検出法としては、A~F型毒素遺伝子を増幅できるPCRを開発した。毒素の検出法としてはイムノクロマト法を開発したが、現在、改良中である。抗体の検出法としては、毒素の一部を結合させたカラムを用いて抗体を濃縮して検出する方法を開発した。治療への応用としては、三叉神経痛と前立腺肥大症に適用できることをとラットを用いて実証した。
Roles of Monocytes/Macrophage for Acquired Immunity in Helicobacter pylori Infection
Grant number:18590425 2006 - 2007
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
YOKOTA Kenji, AYADA Kiyoshi, OGUMA Keiji
Grant amount:\4010000 ( Direct expense: \3500000 、 Indirect expense:\510000 )
We have been studying functions of macrophage in Hefrcobacter pylori inffection. Because we think that acquired immunity may play important roles in the diseases caused by H. pylori infection. To investigate immunity of H.pylori infection, we have shown the H.pylori- HSP60 (heat shock protein 60 kDa) activates macrophage and it is useful antigen.
We have shown some results supporting by this Grant.
1) HSP60 stimulated and activated a macrophage though TLR2 and TLR4. IL8 was produced from the macrophage depending on MAPK and NE-〓B activation.
2) Arteriosclerosis in Apo-E KO mouse was progressed by H. pylori infection. The pathology was associated with immunity to HSP60 and T helper 1.
3) Patients with arteriosclerosis possessed antibody to peptides from H. pylori-HSP60. The peptides might be available for diagnosis of arteriosclerosis.
4) DNA chip study indicated that DEC205 is an important receptor for macrophage activation in patients with gastritis caused by H pylori infection. We are now studying function of DEC205 on macrophage using NOMO-1 cell differenciated by PMA.
Establishment of new procedures for botulism including bio-terrorism and for the treatment of patients with dystonia.
Grant number:17390127 2005 - 2006
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)
OGUMA Keiji, YOKOTA Kenji, AYADA Kiyoshi, KOUICHI Takeshi, ARIMITSU Hideyuki
Grant amount:\14600000 ( Direct expense: \14600000 )
1. Development of vaccine and immuno-strip for detecting toxin
In order to prepare the safe and effective type C and D vaccines for animal botulism, the heavy chains (100 kDa) and their C-terminal (Hc, 50 kDa) and N-terminal (Hn, 50 kDa) half fragments were prepared as GST fusion proteins. Production level of Hc and Hn was quite higher than that of H. H and He showed good vaccine effects but that of Hn was quite low. GST fused-or GST-eliminated He preparation showed similar vaccine effect. Therfore, it was concluded that He with or without GST can be used as commercially effective vaccine. Immuno-strip method was prepared using polyclonal antisera against A, B, E, and F neurotoxins. They could detect approximately 1 ng of each toxin.
2. Development of neurotoxin preparations for treating dystonia
We found that HAI and HA3b, which are the subcomponents of HA, have adjuvant activity. Therefore, we tried to treat the patients with the neurotoxins rather than the progenitor toxins. We found that Type A and B neurotoxins can easily be purified by using a lactose gel column, and that they can be stocked in a deep freezer without reducing the toxin activity by mixing with 0.05% albumin (for type B) or 0.05% albumin plus 1% terehalose (for type A). When this preparation was used for the treatment of 18 patients with urinary incontinence caused by refractory idiopathic and neurogenic detrusor overactivity, 16 patients showed excellent improvement; it started within 1 week after injection in most cases and lasted 3 to 12 months.
Analysis of tertial structure and function of non-toxic components associating with Clostridium botulinum neurotoxins.
Grant number:14370093 2002 - 2003
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)
OGUMA Keiji, NISHIKAWA Jun, FUJINAGA Yukako, YOKOTA Kenji, INOUE Kaoru
Grant amount:\13400000 ( Direct expense: \13400000 )
Clostridium botulinum type A to D hemagglutinin positive progenitor toxins (PTX) consist of three distinct components : neurotoxin (NTX), hemagglutinin (HA), and non-toxic non-HA (NTNH). The HA consists of four subcomponents designated HA1 (〜33kDa), 2 (〜17kDa), 3a (〜22kDa), and 3b (〜53kDa).
We have established an easy procedure for purifying type B HA-positive PTX and NTX by employing an affinity gel column-linked lactose. By employing the purified type A to D toxins and their each HA subcomponents prepared as GST-fusion proteins, we have shown that HA, especially HA1 and HA3b, works as an adhesin in the attachment of HA-positive PTXs to the-microvilli of the upper small intestine as well as erythrocytes. Type A (and B) toxin bound to the galactose mainly via HA1, whereas type C (and D) bound to the sialic acid mainly via HA3b. By analyses of primary and tertiary structure of HA1 and HA3b, It became clear that HA1 has two β-trefoil domains like as lectin B-chain of the ricin, whereas HA3b has carbohydrate recognition domain (CRD) of sialo-adhesin family (or Siglec family). In the binding and internalization tests with C HA-positive toxin and human colon carcinoma HT-29 cells, the toxin bound to glycoproteins with high molecular mass, and internalized within 4 min, but not if the cells were pretreated with neuraminidase, indicating that sialic acid of glycoprotein is the receptor for type C toxin and the toxin can internalize quickly into the cells. It was also found that both HA1 and HA3b have adjuvant activity.
熱ショック蛋白質HSP60の胃MALTリンパ腫発生への関与
Grant number:13877026 2001 - 2002
日本学術振興会 科学研究費助成事業 萌芽研究
赤木 忠厚, 横田 憲治
Grant amount:\2000000 ( Direct expense: \2000000 )
1.HSP60に対するヒト免疫系の反応性、とくにMALTリンパ腫患者リンパ球の反応性
MALTリンパ腫患者では、HSP60に対する自己抗体ができることを報告しているが,この機序を解明するために、MALTリンパ腫患者リンパ球をGM-CSFとIL-4存在下にHSP60で刺激し,リンパ球の反応性を調べた。抗原刺激により,MALTリンパ腫患者のリンパ球はIL-4を産生するが、健常者や胃炎患者のリンパ球はIFN-γを多く産生した。またB細胞の抗原刺激に際してco-stimulatory signalとして働くCD4T細胞のCD40リガンド(CD40L)の発現が、MALTリンパ腫患者では増強した。H.pylori菌全体を使った抗原刺激では,胃炎患者とMALTリンパ腫患者でCD40Lの発現に差は認められなかった。これらの結果より、MALTリンパ腫患者ではHSP60に対するTh-2の液性免疫反応が強く誘導され、B細胞の増殖が起こることが判明した。
2.HSP-60の末梢血並びにリンパ組織単核細胞における発現
HSP60は末梢血中ではTリンパ球の一部と単球の大部分に発現し、マイトゲンで刺激すると,T.B.NK細胞における発現率と発現量が著しく増強した。反応性リンパ組織では、芽中心及び濾胞間のマクロファージとリンパ芽球の胞体内に発現していた。
3.感染動物実験による宿主因子の解析
マウスの系統によって、H.pylori感染後に発症する胃炎の程度が異なることが知られている。あらかじめ感染させたマウスに大腸菌のリコンビナント易熱性毒素をアジュバントとして、rHSP60を鼻腔より免疫した。Th-1優位なC57BL/6でもTh-2優位なBALB/Cマウスでも、HSP60を用いた局所免疫により、感染早期から胃炎が高率に発症することを認めた。またT細胞を活性化しやすいアミノ酸配列を含んだ領域を部分発現させたHSP60を免疫すると,胃炎の発症が強く誘導された。
Roles of HSP60 in Helicobacter pylori infection
Grant number:12670256 2000 - 2002
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
YOKOTA Kenji, OGUMA Keiji
Grant amount:\2200000 ( Direct expense: \2200000 )
We have previously reported that heat shock protein 60kDa (HSP60) is an important antigen in the pathogenesis of mucosa-associated lymphoid tissue (MALT) lymphoma. To investigate association with host immunity and HSP60, DC40 ligand (CD40L) and cytokine production in peripheral blood mononuclear cells (PBMCs) from the patients were analyzed following stimulation with HSP60. PBMCs obtained from patients with gastritis and MALT lymphoma, and those from healthy volunteer were stimulated with recombinant-HSP60 or H. pylori cell fysate in the presence of cytokines (IL-4) and GM-CSF). The mRNA expression was also analyzed by a cDNA microarray containing 1100 genes. The expression of CD40L on the CD4 positive cells was increased in the PBMCs from patients with MALT lymphoma stimulated by cytokines and/or HSP60 antigens. The production of IL-4 in PBMCs cultures was increased in patients with MALT lymphoma ; however, the production of IFN-_γ was at low levels. A cDNA microarray analysis indicated increased mRNA levels of HLA-DR and integrin. In cases of low-grade MALT lymphoma, adaptive immune responses against HSP60 may be enhanced by host factors, such as antigen presentation and T cell activation, resulting in B cell proliferation, which can be demonstrated during H. pylori infection.
To study immunological roles of HSP60 in H. pylori infection, we immunized HSP60 to H. pylori infected mice. Whole HSP60 and two partial regions of helicobacterial hsp60 were expressed as GST-fusion proteins. Three recombinant proteins were designated rHSPw, rHSP2, and rHSP4-5. rHSPw was expressed as whole hsp60 (MeT_1-Met_<545>). rHSP2 (Glu_<101>-Ser_<200>) contained a domainT cell epitope cluster (Lys_<159>-Tnr_<178>). The rHSP4-5 contained a domain existing in both T cell epilope cluster (Asp_<396>-Gly_<4l2>) and its upstream of region (Ser_<356>-Asp_<392>) in common between H. pylori and human hsp60. Recombinant heat-labile enterotoxin (rLT) of E. coli was also employed as adjuvant for nasal immunization. Three different mouse groups (BALB/c, C3H/He, C57BL/6) were injected 10^8 CRJ of live H. pylori (SS -1) at two times a week and kept in a clean isolator for 2 weeks. Those mice were immunized H. pylori lysate or rHSPs (10μg/mouse) with rLT (10μg/mouse) by injecting into nasal mucosa four times in 1 month. Mice were sacrificed at 1 momtn after last immunization, and then histopathology and antibodies were investigated. Mucosal immunization by H. pylori lysate and rHSPs induced severe gastritis in BALB/c and C57BL/6 mice. Inflammation grades in those two groups immunized by rHSP4-5 were highest in aft groups. Mucosal immunization by hsp60 accelerated production of IgG and IgA.
These -results indicated that HSP60 was closely associated with H. pylori induced gastric inflammation.
Physiological aspects of cholesteryl glucosides in Helicobacter pylori
Grant number:09670281 1997 - 1998
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
HIRAI Yosikazu, YOKOTA Kenji
Grant amount:\2700000 ( Direct expense: \2700000 )
We have detected three types of cholesteryl glucosides (CGs) in H.pylofl (HP) cultured in a serum-supplemented medium. The structures of the CGs were cholesteryl glucoside (CGL), acylated CGL (CAG), and phosphatidyl CGL (CPG).
Firstly, we investigated bacterial growth in a serum-supplemented medium with shaking under microaerophlic conditIon using with a chamber (Concept plus, Ruskinn tech., UK). Under this condition, subculture and culture of HP can be done without exposing usual air.
We investigated the lipid, especially CGs, compositions of HP in each bacterial growth phase under the condition mentioned above. In CGs, CGL and CAG were detected at all growth phases. However, little of CPG was detected at exponential phase. CPG was detected In spiral form bacteria of stationary phase, and its content dramatically increased at declining phase (phase of coccoid formation), whereas the content of phosphatidyl ethanolarnine, main phosphoilpid of HP, was dramatically decreased at declining phase. The metabolism of phosphate was appeared to be dramaticaliy changed after stationary phase in HP.
We investigated the uptakes of sterols and those related compounds, and the synthesis of glucosides from those in a serum-free medium under the same condition mentIoned above. HP accumulated free cholesterol, ergosterol, stigmasterol, beta-sitosterol, and synthesize glucosides from those. However, HP did not accumulate cholesterol ester. Therefore, the structure of 3 beta-ol could be important for the accumulation of sterol. HP accumulated vitamin D3, cholecalciferol, but did not synthesize glucoside from it. For the synthesis of glucosides after the accumulation, the base structure of sterol would be important. Furthermore, vitamin D3 inhibited the growth of HP, and its MIC against HP In a serum-free medium was 12.5 mug/ml. The hydrophobic substances which are accumulated but not synthesized to glucosides such as vitamin D3 may inhibited the growth in HP.
In vivoおよびIn vitroの細胞障害実験によるH.pylori病態研究
Grant number:09770181 1997 - 1998
日本学術振興会 科学研究費助成事業 奨励研究(A)
横田 憲治
Grant amount:\1900000 ( Direct expense: \1900000 )
(1) 動物実験による宿主反応の検討
胃十二指腸疾患の原因であるHelicobacter pylori感染の宿主反応について調べるため、各種感染にたいする免疫反応の異なるマウス(BALB/c,C57BL/6,C3H/He)に感染させ、経時的にその病理、抗体価、サイトカインを測定した。感染により誘導された胃炎は、C57BL/6最も頻度が高く、C3H/He,BALB/cの順であった。しかし、リンパ濾胞を伴う激しい炎症はC3H/Heの一部に認められた。抗体価は、全てのマウスで経時的に上昇していた。最も炎症の激しい炎症の認められた2匹のC3H/Heのサイトカインを調べたところ。一方はTh-2優位であり、もう一方はTh-1優位の傾向を認めた。これらの結果より、H.pyloriによる炎症の誘導および病原性には、宿主側の要因が深く関わっていると考えられた。
(2) In vitro細胞傷害(熱ショック蛋白を介した細胞傷害の検討)
胃のMALTリンパ腫は、H.pyloriの感染により発生したリンパ増殖性の疾患である。この患者は、HSP60が腫瘍性リンパ濾胞芽中心の細胞(抗原提示細胞)に発現している事、さらに血清中にHSP60に対する抗体が存在することを認めた。そこでH.pyloriのHSP60をクローニングし蛋白を発現させた。
MALTリンパ腫のリンパ球を重症免疫不全マウス(SCIDマウス)に移植し菌を投与すると、潰瘍性病変が出現した。潰瘍の発生したマウスには、自己抗体とH.pylori反応性のT細胞が存在していた事から、抗体依存性細胞傷害の可能性が示唆された。
Prevention of cattle-botulism in Australia
Grant number:06044152 1994
Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant-in-Aid for international Scientific Research
OGUMA Keiji, YOKOTA Kenji, INOUE Kaoru, HIRST Robert, HOLDEN Janet
Grant amount:\2200000 ( Direct expense: \2200000 )
The type C and D botulinum strains were isolated from the ground of a cattle farm (a pasture) in Australia. The type C toxin was purified from one type C culture, and its antigenicity was analyzed by monoclonal antibodies. Based on the results of antigenicity and toxin-neutralization tests, it was concluded that the C-terminal of the toxin can be used as effective vaccine.
The peptide (15 amino acid residues) which is conserved in the light chain components of any different types of botulinum toxins was synthesized, and the monoclonal antibodies against it were prepared in rats. Though two monoclonal antibodies reacting with any types of toxins were obtained, they did not neutralize the toxigenicity, indicating that this peptide can not be used as vaccine, but the monoclonal antibodies thus obtained can be used for diagnosis of botulism caused by any types of toxins.
Microbes affecting life (2024academic year) Third semester - 金7~8
Laboratory Immunology (2024academic year) 1st semester - 火5~6
Laboratory Exercise in Laboratory Immunology (2024academic year) Second semester - 水3~8
Graduation Thesis in Medical Technology (2024academic year) 1st-4th semester - その他
Risk Management (2024academic year) Late - 木7
Public health basics (2024academic year) Third semester - 月1~2
Genetics (2024academic year) 3rd and 4th semester - [第3学期]水6~7, [第4学期]火3~4
Virology (2024academic year) 1st semester - 木5~6
Infection and Immunity (2024academic year) 1st semester - 水2~3
Seminar in Analysis of Infectious Diseases and Pathogenic Factors (2024academic year) Late - 水7
Topics in Analysis of Infectious Diseases and Pathogenic Factors (2024academic year) Prophase - 水7
Laboratory Management I (2024academic year) Second semester - 火4~7
Calamity Crisis Management Theory (2024academic year) Summer concentration - その他
Seminar in Analysis of Pathogenic Factors (2024academic year) Late - 木1
Topics in Analysis of Pathogenic Factors (2024academic year) Prophase - 木1
Thesis Research on Pathophysiology (2024academic year) special - その他
Pathological Information Analysis Science Special Research (2024academic year) special - その他
Practical Training in Medical Technology (2024academic year) 1st-4th semester - その他
Scientific study (2024academic year) Fourth semester - 月3~8,水3~8,木1~6
Scientific study (2024academic year) Fourth semester - その他
Laboratory Exercise in Clinical Microbiology (2024academic year) Fourth semester - 水3~8,木3~8
Clinical Pharmacology (2024academic year) Second semester - 火3~4,金3~4
Introduction course for Health Sciences (2024academic year) Prophase - 水5
Exercise of Team Medical Activities (2023academic year) 1st and 2nd semester - その他
Microbes affecting life (2023academic year) Third semester - 金7~8
Laboratory Immunology (2023academic year) 1st semester - 火5~6
Laboratory Exercise in Laboratory Immunology (2023academic year) Second semester - 水3~8,木3~8
Graduation Thesis in Medical Technology (2023academic year) 1st-4th semester - その他
Risk Management (2023academic year) Late - 木7
Public health basics (2023academic year) Third semester - 月1~2
Public health basics (2023academic year) Third semester - 月1~2
Public health basics (2023academic year) Third semester - 月1~2
Genetics (2023academic year) 3rd and 4th semester - [第3学期]水6~7, [第4学期]火3~4
Genetics (2023academic year) 3rd and 4th semester - [第3学期]水6~7, [第4学期]火1~2
Genetics (2023academic year) 3rd and 4th semester - [第3学期]水6~7, [第4学期]火3~4
Genetics (2023academic year) 3rd and 4th semester - [第3学期]水6~7, [第4学期]火3~4
Virology (2023academic year) 1st semester - 木5~6
Infection and Immunity (2023academic year) 1st semester - 水2~3
Infection and Immunity (2023academic year) 1st semester - 水2~3
Infection and Immunity (2023academic year) 1st semester - 水2~3
Seminar in Analysis of Infectious Diseases and Pathogenic Factors (2023academic year) Late - 水7
Topics in Analysis of Infectious Diseases and Pathogenic Factors (2023academic year) Prophase - 水7
Calamity Crisis Management Theory (2023academic year) Summer concentration - その他
Calamity Crisis Management Theory (2023academic year) Summer concentration - その他
Calamity Crisis Management Theory (2023academic year) Summer concentration - その他
Seminar in Analysis of Pathogenic Factors (2023academic year) Late - 木1
Topics in Analysis of Pathogenic Factors (2023academic year) Prophase - 木1
Thesis Research on Pathophysiology (2023academic year) Year-round - その他
Pathological Information Analysis Science Special Research (2023academic year) Year-round - その他
Practical Training in Medical Technology (2023academic year) 1st-4th semester - その他
Scientific study (2023academic year) special - その他
Laboratory Exercise in Clinical Microbiology (2023academic year) Fourth semester - 水3~8,木3~8
Laboratory Science Exercise (2023academic year) 2nd and 3rd semester - [第2学期]火7, [第3学期]月7
Clinical Pharmacology (2023academic year) Second semester - 火3~4,金3~4
Clinical Pharmacology (2023academic year) Second semester - 火3~4,金3~4
Clinical Pharmacology (2023academic year) Second semester - 火3~4,金3~4
Analytical Biochemistry (2023academic year) Second semester - 火2~5
Laboratory Exercise in Analytical Biochemistry (2023academic year) special - その他
Introduction course for Health Sciences (2023academic year) Prophase - 水5
Microbes affecting life (2022academic year) Third semester - 金7~8
Laboratory Immunology (2022academic year) 1st semester - 火5~6
Laboratory Exercise in Laboratory Immunology (2022academic year) Second semester - 水3~8,木3~8
Graduation Thesis in Medical Technology (2022academic year) 1st-4th semester - その他
Risk Management (2022academic year) Late - 木7
Fundamental Microbiology (2022academic year) Third semester - 水4~5
Fundamental Microbiology (2022academic year) Third semester - 水4~5
Genetics (2022academic year) 3rd and 4th semester - [第3学期]水6~7, [第4学期]火1~2
Genetics (2022academic year) 3rd and 4th semester - [第3学期]水6~7, [第4学期]火1~2
Genetics (2022academic year) 3rd and 4th semester - [第3学期]水6~7, [第4学期]火1~2
Genetics (2022academic year) 3rd and 4th semester - [第3学期]水6~7, [第4学期]火1~2
Infection and Immunity (2022academic year) 1st semester - 水2~3
Infection and Immunity (2022academic year) 1st semester - 水2~3
Infection and Immunity (2022academic year) 1st semester - 水2~3
Seminar in Analysis of Infectious Diseases and Pathogenic Factors (2022academic year) Late - 水7
Topics in Analysis of Infectious Diseases and Pathogenic Factors (2022academic year) Prophase - 水7
Calamity Crisis Management Theory (2022academic year) Summer concentration - その他
Calamity Crisis Management Theory (2022academic year) Summer concentration - その他
Calamity Crisis Management Theory (2022academic year) Summer concentration - その他
Seminar in Analysis of Pathogenic Factors (2022academic year) Late - 木1
Topics in Analysis of Pathogenic Factors (2022academic year) Prophase - 木1
Thesis Research on Pathophysiology (2022academic year) Year-round - その他
Pathological Information Analysis Science Special Research (2022academic year) Year-round - その他
Practical Training in Medical Technology (2022academic year) 1st-4th semester - その他
Scientific study (2022academic year) special - その他
Clinical Microbiology (2022academic year) Third semester - 木4~5
Laboratory Exercise in Clinical Microbiology (2022academic year) Fourth semester - 水3~8,木3~8
Laboratory Science Exercise (2022academic year) 2nd and 3rd semester - [第2学期]火7, [第3学期]月7
Clinical Pharmacology (2022academic year) Second semester - 火3~4,金3~4
Clinical Pharmacology (2022academic year) Second semester - 火3~4,金3~4
Clinical Pharmacology (2022academic year) Second semester - 火3~4,金3~4
Introduction course for Health Sciences (2022academic year) Prophase - 水5
Microbes affecting life (2021academic year) Third semester - 金3~4
Laboratory Immunology (2021academic year) 1st semester - 火5~6
Laboratory Exercise in Laboratory Immunology (2021academic year) Second semester - 水3~8,木3~8
Graduation Thesis in Medical Technology (2021academic year) 1st-4th semester - その他
Risk Management (2021academic year) Late - 木7
Fundamental Microbiology (2021academic year) Third semester - 水4~5
Fundamental Microbiology (2021academic year) Third semester - 水4~5
Genetics (2021academic year) 3rd and 4th semester - [第3学期]水6~7, [第4学期]火1~2
Genetics (2021academic year) 3rd and 4th semester - [第3学期]水6~7, [第4学期]火1~2
Genetics (2021academic year) 3rd and 4th semester - [第3学期]水6~7, [第4学期]火1~2
Genetics (2021academic year) 3rd and 4th semester - [第3学期]水6~7, [第4学期]火1~2
Infection and Immunity (2021academic year) 1st semester - 水2~3
Infection and Immunity (2021academic year) 1st semester - 水2~3
Infection and Immunity (2021academic year) 1st semester - 水2~3
Seminar in Analysis of Infectious Diseases and Pathogenic Factors (2021academic year) Late - 水7
Topics in Analysis of Infectious Diseases and Pathogenic Factors (2021academic year) Prophase - 水7
Calamity Crisis Management Theory (2021academic year) Summer concentration - その他
Calamity Crisis Management Theory (2021academic year) Summer concentration - その他
Calamity Crisis Management Theory (2021academic year) Summer concentration - その他
Seminar in Analysis of Pathogenic Factors (2021academic year) Late - 木1
Topics in Analysis of Pathogenic Factors (2021academic year) Prophase - 木1
Thesis Research on Pathophysiology (2021academic year) Year-round - その他
Pathological Information Analysis Science Special Research (2021academic year) Year-round - その他
Practical Training in Medical Technology (2021academic year) 1st-4th semester - その他
Scientific study (2021academic year) special - その他
Clinical Microbiology (2021academic year) Third semester - 木4~5
Laboratory Exercise in Clinical Microbiology (2021academic year) Fourth semester - 水3~8,木3~8
Laboratory Science Exercise (2021academic year) 2nd and 3rd semester - [第2学期]火7, [第3学期]月7
Clinical Pharmacology (2021academic year) Second semester - 火3~4,金3~4
Introduction course for Health Sciences (2021academic year) Prophase - 水5
Microbes affecting life (2020academic year) Third semester - 金3,金4
Laboratory Immunology (2020academic year) 1st semester - 火5,火6
Laboratory Exercise in Laboratory Immunology (2020academic year) Second semester - 水3~8,木3~8
Graduation Thesis in Medical Technology (2020academic year) 1st-4th semester - その他
Risk Management (2020academic year) Late - 木7
Fundamental Microbiology (2020academic year) Third semester - 水4,水5
Fundamental Microbiology (2020academic year) Third semester - 水4,水5
Genetics (2020academic year) 3rd and 4th semester - [第3学期]水6,水7, [第4学期]火1,火2
Genetics (2020academic year) 3rd and 4th semester - [第3学期]水6,水7, [第4学期]火1,火2
Genetics (2020academic year) 3rd and 4th semester - [第3学期]水6,水7, [第4学期]火1,火2
Genetics (2020academic year) 3rd and 4th semester - [第3学期]水6,水7, [第4学期]火1,火2
Infection and Immunity (2020academic year) 1st semester - 水2,水3
Infection and Immunity (2020academic year) 1st semester - 水2,水3
Infection and Immunity (2020academic year) 1st semester - 水2,水3
Infection and Immunity (2020academic year) 1st semester - 水2,水3
Infection and Immunity (2020academic year) 1st semester - 水2,水3
Infection and Immunity (2020academic year) 1st semester - 水2,水3
Seminar in Analysis of Infectious Diseases and Pathogenic Factors (2020academic year) Late - 水7
Topics in Analysis of Infectious Diseases and Pathogenic Factors (2020academic year) Prophase - 水7
Calamity Crisis Management Theory (2020academic year) Summer concentration - その他
Calamity Crisis Management Theory (2020academic year) Summer concentration - その他
Calamity Crisis Management Theory (2020academic year) Summer concentration - その他
Seminar in Analysis of Pathogenic Factors (2020academic year) Late - 木1
Topics in Analysis of Pathogenic Factors (2020academic year) Prophase - 木1
Thesis Research on Pathophysiology (2020academic year) Year-round - その他
Pathological Information Analysis Science Special Research (2020academic year) Year-round - その他
Practical Training in Medical Technology (2020academic year) 1st-4th semester - その他
Scientific study (2020academic year) special - その他
Clinical Microbiology (2020academic year) Third semester - 木4,木5
Laboratory Exercise in Clinical Microbiology (2020academic year) Fourth semester - 水3~8,木3~8
Clinical Pharmacology (2020academic year) Second semester - 火3,火4,金3,金4
Introduction course for Health Sciences (2020academic year) Prophase - 水5